syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187	100.0
OCULOFACIOCARDIODENTAL SYNDROME	2.0	75.03230046744748
CHILDHOOD ABSENCE EPILEPSY	1.5207408500000001	57.052342195160755
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	1.2909091	48.4299397336811
MYOCLONIC-ASTASTIC EPILEPSY	1.2186896	45.7205421218767
BEHR SYNDROME	1.2023546200000002	45.10771655813183
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.78280343709462
260150 PALANT CLEFT PALATE SYNDROME	1.166667	43.76885444472777
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.15287269	43.25134503839722
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.00342466	37.64463029278317
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	1.00120482	37.56135044184834
DUPLICATION OF THE PITUITARY GLAND	1.00075643	37.54452857524504
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	1.00075643	37.54452857524504
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	1.000541419	37.53646219026713
ANAPLASTIC THYROID CARCINOMA	1.0	37.51615023372374
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.51615023372374
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.05661993667499
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.833333	31.26344602271971
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.8257141090000001	30.97761456334934
%187370 ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10;;CONGENITAL PLANTAR CONTRACTURES;;TENDO CALCANEUS, SHORT	0.79684233	29.894456564870474
LAFORA DISEASE	0.7715289599999999	28.944796373028638
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.910586896276513
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7480334099999999	28.063333789404666
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.7099728599999999	26.63544847762651
EARLY MYOCLONIC ENCEPHALOPATHY	0.70818336	26.568313326783265
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.6969696000000001	26.147616221938346
15Q OVERGROWTH SYNDROME	0.6672074189999999	25.03105376825906
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59274141	22.23737578730924
ROLANDIC EPILEPSY	0.5906213	22.157837422037222
MUCOPOLYSACCHARIDOSIS TYPE 2	0.5872993790000001	22.033211734736664
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.56408717	21.162379014636063
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.842307352786534
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	20.00860095260259
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.772024109228724
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5231222799999999	19.625534047088095
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.51630151	19.369645015058424
WIEACKER-WOLFF SYNDROME	0.5156349490000001	19.344638212442483
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.51341463	19.261340391271688
ARTHROGRYPOSIS-LIKE HAND ANOMALY AND SENSORINEURAL DEAFNESS	0.50719424	19.027975305519337
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.50714286	19.02604772572033
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.022273225845314
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.50704225	19.022273225845314
INHALATIONAL ANTHRAX	0.5035461	18.89111113720568
PAROXYSMAL HEMICRANIA	0.50342466	18.886555175921295
NON-DISTAL MONOSOMY 20Q	0.5012978490000001	18.806765414926563
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.500541419	18.778387073405263
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.75807511686187
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.5	18.75807511686187
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.75807511686187
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.5	18.75807511686187
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.5	18.75807511686187
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.5	18.75807511686187
CREST SYNDROME	0.5	18.75807511686187
BENIGN SCHWANNOMA	0.5	18.75807511686187
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.5	18.75807511686187
MYOPATHIC EHLERS-DANLOS SYNDROME	0.47007909999999997	17.635558137333646
ULNAR HEMIMELIA	0.4455281	16.714499132945495
ANOCTAMIN-5-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R12	0.4383321	16.44453291586362
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42149728000000003	15.812955279585921
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.41534218	15.582039623282329
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.340027440062606
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.39780377	14.924065998861686
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.377126619	14.148338895540293
CALPAIN-3-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R1	0.3716651	13.94344372823196
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.36781579999999997	13.799032811137286
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752804
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769365
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769365
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.307012252437023
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34973511999999995	13.120715303929401
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.34825196	13.065072850548754
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.34603212	12.981792999613923
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.3448273	12.936592791489327
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.34447437999999997	12.923352591748841
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.34406480899999997	12.907987064581464
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841279
EMERY-NELSON SYNDROME	0.33814068999999997	12.685736926175007
COG4-CDG	0.33529424999999996	12.578949455503727
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.333333	12.505370905857834
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857834
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857834
FRASER-LIKE SYNDROME	0.333333	12.505370905857834
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.505370905857834
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.3176271599999999	11.916148252871004
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30073585999999997	11.282451704428109
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.2934783	11.010175993137848
PALLISTER-HALL SYNDROME	0.2934783	11.010175993137848
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.2924201	10.97047640296052
SCHWARTZ-JAMPEL SYNDROME	0.28771257	10.79386800025076
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.28538657999999995	10.706605809968618
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.266667	10.004319234376409
STUVE-WIEDEMANN SYNDROME	0.26294890000000004	9.864830436192403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25508440000000004	9.569784672679283
SCLERODERMA	0.254087519	9.532385535318136
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.251297849	9.427727856495624
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.25120482	9.42423776655553
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.25119335000000004	9.423807456312352
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.25075643	9.40741589995223
EXTRAORAL HALITOSIS DUE TO METHANETHIOL OXIDASE DEFICIENCY; EHMTO	0.25	9.379037558430936
WILD TYPE ABETA2M AMYLOIDOSIS	0.25	9.379037558430936
MUCOPOLYSACCHARIDOSIS TYPE 1	0.25	9.379037558430936
DYSTONIA 6, TORSION	0.25	9.379037558430936
PRIMARY CILIARY DYSKINESIA	0.25	9.379037558430936
HYPERPARATHYROIDISM 2	0.25	9.379037558430936
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.379037558430936
IDIOPATHIC BRONCHIECTASIS	0.25	9.379037558430936
HYPEREKPLEXIA 1; HKPX1	0.25	9.379037558430936
MICROPHTHALMIA WITH LIMB ANOMALIES	0.25	9.379037558430936
METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	0.25	9.379037558430936
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.379037558430936
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.24265660000000003	9.10354146080461
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.2424996	9.097651425217915
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.23749391	8.909857207154467
ARTHROGRYPOSIS, DISTAL, TYPE 1B	0.2371406	8.89660237611539
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.23544956	8.833161065424152
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.725180206013935
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.475991933577507
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.22510605	8.445112390320128
JUVENILE MYOCLONIC EPILEPSY	0.2214368	8.307456256075037
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.21705794	8.143178286462595
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.21234543	7.966383053324669
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.20962820000000001	7.864443044425089
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2087344	7.830911109346185
KUFOR-RAKEB SYNDROME	0.20475092	7.681466275213151
BETHLEM MYOPATHY 2; BTHLM2	0.20409836	7.656984736216634
SARCOIDOSIS	0.2035461	7.636266067088557
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.20342466	7.631710105804173
FAMILIAL CERVICAL ARTERY DISSECTION	0.20342466	7.631710105804173
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.20342466	7.631710105804173
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.20308968000000002	7.61914294579888
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.20196125	7.57680859639064
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.200541419	7.523542003288142
WHIM SYNDROME	0.200541419	7.523542003288142
SALIVARY DUCT CALCULI	0.2	7.50323004674475
RADIATION PROCTITIS	0.2	7.50323004674475
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.2	7.50323004674475
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.2	7.50323004674475
MYOFIBROMATOSIS, INFANTILE, 1; IMF1	0.2	7.50323004674475
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.2	7.50323004674475
MELIOIDOSIS	0.2	7.50323004674475
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.2	7.50323004674475
RAT-BITE FEVER	0.2	7.50323004674475
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.2	7.50323004674475
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.50323004674475
RIGID SPINE SYNDROME	0.19969540000000002	7.491802627383557
TRANSIENT NEONATAL DIABETES MELLITUS	0.19016275	7.134174297858049
PERMANENT NEONATAL DIABETES MELLITUS	0.19016275	7.134174297858049
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.18953489999999998	7.110619782933806
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.18953489999999998	7.110619782933806
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.18953489999999998	7.110619782933806
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.18953489999999998	7.110619782933806
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.18953489999999998	7.110619782933806
ROBERTS SYNDROME	0.18823045	7.061681840761425
ZUNICH NEUROECTODERMAL SYNDROME	0.187009479	7.015875709294406
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.18074025999999999	6.780678747442289
MYOCLONIC EPILEPSY OF INFANCY	0.18074025999999999	6.780678747442289
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.17932520000000002	6.727591143892557
DUPUYTREN CONTRACTUREDUPUYTREN CONTRACTURE 1, INCLUDED	0.17932520000000002	6.727591143892557
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.1773398	6.653106579218522
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.174351279	6.540988776405883
PORPHYRIA	0.17417917900000002	6.5345322469506595
GRANULOMATOSIS WITH POLYANGIITIS	0.17417917900000002	6.5345322469506595
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.17198444899999998	6.452194426548198
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.17076536	6.40645890047592
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17064042999999998	6.401772007827219
PFAPA SYNDROME	0.1702131	6.385740231347843
UNILATERAL POLYMICROGYRIA	0.16875813	6.331155358242283
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.167964849	6.301394509068723
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.16742343	6.281082552525332
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.16742343	6.281082552525332
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.166667	6.252704211004036
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	6.252704211004036
SYNPOLYDACTYLY 1	0.166667	6.252704211004036
GRAFT VERSUS HOST DISEASE	0.166667	6.252704211004036
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.166667	6.252704211004036
CRANIOACROFACIAL SYNDROME	0.166667	6.252704211004036
PEYRONIE DISEASE	0.166667	6.252704211004036
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.166667	6.252704211004036
PITYRIASIS RUBRA PILARIS	0.166667	6.252704211004036
PEMPHIGUS VULGARIS	0.166667	6.252704211004036
FASCIAL DYSTROPHY, CONGENITAL	0.166667	6.252704211004036
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.16361055999999996	6.138038348783671
CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME	0.1625	6.096374412980109
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.15950570000000003	5.98403980433527
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.15950570000000003	5.98403980433527
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.15699616	5.88989152467773
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15621461999999997	5.860571152624065
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15510773	5.819044901091859
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.6871294881555325
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.15147173000000003	5.68263617884204
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.15010410000000002	5.631327966297893
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.14880960000000001	5.582763309820337
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.148123149	5.557010310976247
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.14771178999999998	5.541577704932251
AMISH NEMALINE MYOPATHY	0.1458333	5.471103991879705
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.14481824999999998	5.433023223584963
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.3594446739390715
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3594446739390715
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14089111	5.285692049356098
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13702114999999998	5.1405060485975955
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.13699983000000002	5.139706204274614
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.135780649	5.0939672267165115
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.134908219	5.061237011768103
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.13434641900000002	5.040160438566799
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.13349208899999998	5.00810926593762
BLAU SYNDROME	0.13323235	4.998364858592064
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.970090811968418
INSULIN-RESISTANCE SYNDROME TYPE B	0.1285461	4.822554799559276
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.126297849	4.738209077280155
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.126297849	4.738209077280155
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.125541419	4.709830735758859
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.125541419	4.709830735758859
VAN DER WOUDE SYNDROME	0.125	4.689518779215468
KIMURA DISEASE	0.125	4.689518779215468
CHEILITIS GLANDULARIS	0.125	4.689518779215468
SEVERE HEMOPHILIA A	0.125	4.689518779215468
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.125	4.689518779215468
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.125	4.689518779215468
HEARING LOSS-FAMILIAL SALIVARY GLAND INSENSITIVITY TO ALDOSTERONE SYNDROME	0.125	4.689518779215468
OXOGLUTARIC ACIDURIA	0.125	4.689518779215468
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.12425806	4.661684046711059
FRONTOMETAPHYSEAL DYSPLASIA	0.12246399	4.594377447061242
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.12157512000000001	4.561030466602992
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.12084480000000002	4.5336316717643
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.12080790899999999	4.532247663466026
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12037025999999999	4.515828757832387
ROBERTS SYNDROME; RBS	0.11841273	4.442389768265366
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.432655077602719
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.11808175999999998	4.429973048022511
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.11438980000000001	4.291464922005613
SCHINZEL-GIEDION SYNDROME	0.11428576000000001	4.2875617417352965
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.11231581999999998	4.213657176743873
FG SYNDROME TYPE 1	0.11165241899999999	4.188768925162671
TERMINAL OSSEOUS DYSPLASIA; TOD	0.11139679000000002	4.179178709194575
BILATERAL POLYMICROGYRIA	0.11130945	4.175902048633161
HYALINE FIBROMATOSIS SYNDROME; HFS	0.11111099999999999	4.168456968619278
JUVENILE HYALINE FIBROMATOSIS	0.11111099999999999	4.168456968619278
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.10815050000000001	4.05739040585234
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10621331	3.984714494781073
AICARDI SYNDROME; AIC	0.10564795000000002	3.9635043640849346
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.104843949	3.9333413417808702
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.10310420000000001	3.8680726569279
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.1017026	3.8154900207603126
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.10056594000000002	3.7728469134356484
CAMPTOBRACHYDACTYLY	0.1	3.751615023372375
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.1	3.751615023372375
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.09940118900000001	3.7291499399347687
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.09860473000000002	3.6992698644357667
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.09860473000000002	3.6992698644357667
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.09860473000000002	3.6992698644357667
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09840755	3.6918724299326806
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.681154065810906
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.09674793000000001	3.629609876681789
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.09653291900000001	3.621543491703885
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.09599150000000001	3.601231535160493
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.09571679000000001	3.5909254735297864
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.09397259000000001	3.5254898042921257
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.093155839	3.4948484510725817
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.0925926	3.4737178921310887
MARDEN-WALKER SYNDROME	0.09252750900000001	3.471275928396226
TRICHOTHIODYSTROPHY	0.09252131000000001	3.471043365780927
OCULODENTODIGITAL DYSPLASIA; ODDD	0.09220694900000001	3.4592497512773037
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.09177107900000002	3.4428975868749307
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.09166553000000001	3.438937794733911
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.09166553000000001	3.438937794733911
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0909091	3.410559453212615
WT LIMB-BLOOD SYNDROME	0.0909091	3.410559453212615
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.0902778	3.3868755075700654
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.08943883900000002	3.355400920653831
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.08913404	3.3439660355787417
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.08897280900000001	3.3379172691604087
CAMPTODACTYLY-TAURINURIA SYNDROME	0.08814099000000002	3.3067106225891427
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.08583596900000001	3.2202351084612544
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.08583596900000001	3.2202351084612544
3Q29 MICRODUPLICATION SYNDROME	0.08463114900000002	3.1750349003366596
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.08463114900000002	3.1750349003366596
MONOSOMY 22	0.08408973000000002	3.154722943793267
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.08387471900000001	3.146656558815364
8P INVERTED DUPLICATION/DELETION SYNDROME	0.08387471900000001	3.146656558815364
MANDIBULOACRAL DYSPLASIA	0.08333330000000001	3.1263446022719714
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.08333330000000001	3.1263446022719714
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904280999999999	2.965381934855681
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.07862284000000001	2.9496262772420248
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.07845034000000001	2.9431547413267074
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07812792	2.93105878416835
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.07759372	2.911017656713495
WHITE-SUTTON SYNDROME; WHSUS	0.07714533000000001	2.894195790110196
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07692310000000001	2.885858576043755
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.07692310000000001	2.885858576043755
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.885858576043755
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.8628236598002488
BLAU SYNDROME	0.07623629000000001	2.8600921089017315
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.07623629000000001	2.8600921089017315
URBAN-ROGERS-MEYER SYNDROME	0.07623629000000001	2.8600921089017315
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.07610066	2.855003793445531
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.07598959999999999	2.8508372498005734
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.07552696	2.833480778056444
TUBEROUS SCLEROSIS COMPLEX	0.07495486	2.81201778850773
JUVENILE ABSENCE EPILEPSY	0.07412774999999999	2.780987805487915
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07409842999999999	2.7798878319630624
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.0737813	2.7679903352394413
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.07272644900000001	2.7284163866492483
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.07272644900000001	2.7284163866492483
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0726819	2.7267450796724857
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07218503000000001	2.708104430105856
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.07197001900000001	2.7000380451279526
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.07197001900000001	2.7000380451279526
LOCALIZED SCLERODERMA	0.07142860000000001	2.67972608858456
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.07142860000000001	2.67972608858456
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.07142860000000001	2.67972608858456
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07142860000000001	2.67972608858456
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07142860000000001	2.67972608858456
LETHAL CONGENITAL CONTRACTURE SYNDROME 6; LCCS6	0.07142860000000001	2.67972608858456
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07142860000000001	2.67972608858456
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.07142860000000001	2.67972608858456
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.07142860000000001	2.67972608858456
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.07129617999999999	2.6747581999706096
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.07098874	2.6632242347427537
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07077939999999999	2.655370603852826
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.07021279999999999	2.634113953130398
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.06960179	2.6111912101760906
MICROHYDRANENCEPHALY; MHAC	0.06898579	2.588081261632117
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.0688549	2.583170772728025
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5771231693103487
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.06866700900000001	2.576121825744461
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067964549	2.549768230851279
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.06787151999999999	2.5462781409111854
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.06787151999999999	2.5462781409111854
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.06787151999999999	2.5462781409111854
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.06776525	2.5422912996258478
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.06742313	2.5294562743078863
LETHAL CONGENITAL CONTRACTURE SYNDROME 4; LCCS4	0.0667341	2.503606521312344
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.5010779327865906
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.5010779327865906
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.5010779327865906
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.5010779327865906
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.5010779327865906
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.5010779327865906
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.06535621900000001	2.4519137307121506
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4316017741687577
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.4316017741687577
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.06470255	2.427390586305022
OTOONYCHOPERONEAL SYNDROME	0.0637945	2.3933240460852896
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.06348501	2.381713172749454
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.3484303449081043
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.06255615	2.346865921443358
SLC39A8-CDG	0.06231383900000001	2.337775345564074
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.061775079999999996	2.3175631819803026
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.060792330000000006	2.280694185338111
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.06078013	2.2802364883052597
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.060516769000000005	2.270356197463556
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.0593361	2.2260620418832553
CONGENITAL ISOLATED ACTH DEFICIENCY	0.05910170000000001	2.2172682562684707
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.05910170000000001	2.2172682562684707
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.059050269	2.2153387631458
BETHLEM MYOPATHY	0.05836648999999999	2.1896860074551343
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.057777909999999995	2.167604751750569
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.05734132000000001	2.1512255757200283
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0573294	2.150778383209242
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.056760420000000006	2.129432444049258
AMISH INFANTILE EPILEPSY SYNDROME	0.0562121	2.1088615885531024
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.084232235924663
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.084232235924663
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.084232235924663
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.084232235924663
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.084232235924663
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	2.084232235924663
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.084232235924663
GITELMAN SYNDROME	0.055555600000000004	2.084232235924663
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.055480230000000005	2.081404643681547
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.055480230000000005	2.081404643681547
DISTAL MONOSOMY 12Q	0.05461823	2.049065722180077
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.054351269	2.039050373197532
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.05281559	1.9814376091227577
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.051850299	1.9452236069474962
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.05149209	1.931784984288424
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.051401908999999996	1.9284017403441964
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340927
HYPEREKPLEXIA 4; HKPX4	0.05116257900000001	1.9194230001087598
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.05067254	1.9010386233643757
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.04976443	1.8669698321756287
ERYTHERMALGIA, PRIMARY	0.0494995	1.8570306784942086
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.0485313	1.820707541837917
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.04818926900000001	1.8078758554573267
CHROMOSOME 17Q12 DELETION SYNDROME	0.047860299999999995	1.7955342050310883
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.04757886	1.7849756597093092
BETHLEM MYOPATHY 1	0.04730579	1.7747311245649864
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.04680156	1.7558143561326358
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.0466779	1.7511751089947336
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.04633119	1.7381678845471993
CHRISTIANSON SYNDROME	0.04619249	1.732964394509782
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6854321824866583
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.04423473000000001	1.6595167762282068
3P25.3 MICRODELETION SYNDROME	0.04388511	1.646400379783492
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.0437524	1.6414216114859745
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.043664970000000004	1.6381415744710404
GABRIELE-DE VRIES SYNDROME	0.043478300000000004	1.6311384347069111
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.043466879	1.6307099627550916
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.04305686	1.6153276283524105
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.0429612	1.6117388334210523
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.042756550000000004	1.604061153275721
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.604061153275721
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.604061153275721
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.042721209999999996	1.6027353325264608
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.0427032	1.6020596666607516
16P13.11 MICRODELETION SYNDROME	0.042601120000000006	1.5982300180448934
GENITOPATELLAR SYNDROME	0.041983589	1.5750626322749115
PSEUDOXANTHOMA ELASTICUM; PXE	0.041886160000000006	1.5714074712737902
COG2-CDG	0.041666699999999994	1.5631741769434968
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.041482029999999996	1.556246069479835
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.041110509	1.542308031828852
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.041110509	1.542308031828852
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.041110509	1.542308031828852
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.04097907	1.5373769465582816
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.04073417	1.5281892413660427
PEHO SYNDROME	0.04020877	1.5084782560332441
CHROMOSOME 1P36 DELETION SYNDROME	0.039568459	1.4844562523609384
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.474397834837925
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.03929049	1.4740279255966204
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938224
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.038998250000000005	1.4630642058523171
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4451708779983423
BAZEX SYNDROME; BZX	0.0384615	1.4429274122143658
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0384615	1.4429274122143658
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.4429274122143658
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.4429274122143658
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	1.4429274122143658
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.4429274122143658
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.4429274122143658
ACROCEPHALOPOLYDACTYLY	0.0384615	1.4429274122143658
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	1.4429274122143658
MAL DE MELEDA	0.0384615	1.4429274122143658
ABLEPHARON-MACROSTOMIA SYNDROME	0.0384615	1.4429274122143658
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	1.4429274122143658
SHPRINTZEN OMPHALOCELE SYNDROME	0.0384615	1.4429274122143658
CYCLIC NEUTROPENIA	0.0384615	1.4429274122143658
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.4429274122143658
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.4429274122143658
LIP, HAMARTOMATOUS	0.0384615	1.4429274122143658
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.4429274122143658
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.038416580000000006	1.4412421867458671
CANAVAN DISEASE	0.03824182	1.4346858643310214
ZELLWEGER SYNDROME	0.038216969	1.4337535504815633
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.038216969	1.4337535504815633
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4212340735032172
SLC35A2-CDG	0.037822220000000004	1.4189440876929509
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.03779343	1.417863997727722
LISSENCEPHALY 2; LIS2	0.03779343	1.417863997727722
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.03771083	1.4147651637184164
OLIVER SYNDROME	0.03745967	1.4053426074257143
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.037037	1.3894856562064262
MCLEOD SYNDROME; MCLDS	0.037037	1.3894856562064262
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.3894856562064262
MYOCLONUS AND ATAXIA	0.037037	1.3894856562064262
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.3894856562064262
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3894856562064262
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.037012149	1.388553342356968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.037012149	1.388553342356968
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.037012149	1.388553342356968
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.0369544	1.3863868221971207
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.03647073000000001	1.3682413858135758
YOU-HOOVER-FONG SYNDROME; YHFS	0.03647073000000001	1.3682413858135758
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.036255719000000006	1.3601750008356726
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.036255719000000006	1.3601750008356726
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.036255719000000006	1.3601750008356726
LISSENCEPHALY, X-LINKED, 2	0.036255719000000006	1.3601750008356726
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.036255719000000006	1.3601750008356726
MENTAL RETARDATION, X-LINKED 98; MRX98	0.036220379	1.3588491800864124
THUMBS, CONGENITAL CLASPED	0.0361093	1.3546819236346006
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.035804199999999994	1.3432357461982913
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.035780649000000005	1.3423522033441373
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.03572847	1.3403946481410915
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.035714300000000004	1.33986304429228
ROWLEY-ROSENBERG SYNDROME	0.03568276	1.3386797849139083
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.03568276	1.3386797849139083
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3380603932735493
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3380603932735493
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.03566625	1.3380603932735493
ALPERS-HUTTENLOCHER SYNDROME	0.03557648	1.334692568467068
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.0354509	1.3299812903207169
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.03527407	1.3233473094748875
FETAL AKINESIA DEFORMATION SEQUENCE	0.03525773	1.3227342955800687
RESTRICTIVE DERMOPATHY	0.03525773	1.3227342955800687
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.03523923	1.3220402468007448
DOORS SYNDROME	0.03482568	1.3065254428715882
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457726
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.3063142269457726
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03469632	1.3016723536773538
ALPHA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R3	0.0344828	1.2936619052794491
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.0344828	1.2936619052794491
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0344828	1.2936619052794491
MYOPATHY, SCAPULOHUMEROPERONEAL	0.0344828	1.2936619052794491
COSTELLO SYNDROME; CSTLO	0.0344828	1.2936619052794491
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.0344828	1.2936619052794491
MYOTILINOPATHY	0.0344828	1.2936619052794491
MYOPATHY AND DIABETES MELLITUS	0.0344828	1.2936619052794491
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.0344828	1.2936619052794491
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.03424793	1.2848504870740545
GENITOPATELLAR SYNDROME; GTPTS	0.03424793	1.2848504870740545
AICARDI SYNDROME	0.03421935	1.2837782755003746
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2781471013502925
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.2781471013502925
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.0334915	1.2564721455527588
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.0334915	1.2564721455527588
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.0334915	1.2564721455527588
PRIMROSE SYNDROME; PRIMS	0.0334915	1.2564721455527588
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.03346292	1.255399933979079
ALG13-CDG	0.03346292	1.255399933979079
SPINOCEREBELLAR ATAXIA TYPE 34	0.03346292	1.255399933979079
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.0330284	1.2390984163795213
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.03301453	1.2385780673757796
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.03301453	1.2385780673757796
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2305116823978763
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.032799519	1.2305116823978763
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978763
PROGRESSIVE HEMIFACIAL ATROPHY	0.032799519	1.2305116823978763
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978763
HYDROXYKYNURENINURIA	0.0322581	1.2101997258544839
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	1.2101997258544839
DESMOID TUMOR	0.0322581	1.2101997258544839
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	1.2101997258544839
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	1.2101997258544839
NETHERTON SYNDROME; NETH	0.0322581	1.2101997258544839
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	1.2101997258544839
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.0322581	1.2101997258544839
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	1.2101997258544839
THROMBOCYTOPENIA 1	0.0322581	1.2101997258544839
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	1.2101997258544839
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	1.2101997258544839
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.2101997258544839
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0322581	1.2101997258544839
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	1.2101997258544839
WEST SYNDROME	0.0322581	1.2101997258544839
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	1.2101997258544839
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	1.2101997258544839
INFANTILE MYOFIBROMATOSIS	0.0322581	1.2101997258544839
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	1.2101997258544839
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1715134468949702
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.031125359999999998	1.1677036818387356
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.031114519	1.1672969692540518
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.030844418999999998	1.157163857075923
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.030844418999999998	1.157163857075923
LETHAL CONGENITAL CONTRACTURE SYNDROME 3; LCCS3	0.03045004	1.1423682752628974
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.030302999999999997	1.1368519005325306
KLHL9-RELATED EARLY-ONSET DISTAL MYOPATHY	0.030302999999999997	1.1368519005325306
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.030302999999999997	1.1368519005325306
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Y; LGMD2Y	0.030302999999999997	1.1368519005325306
DISTAL NEBULIN MYOPATHY	0.030302999999999997	1.1368519005325306
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.030302999999999997	1.1368519005325306
AYMÉ-GRIPP SYNDROME	0.030275419999999997	1.1358172051090842
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.030267259999999997	1.1355110733231772
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029921848999999997	1.1225525823547964
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.02973905	1.115694667608222
STÜVE-WIEDEMANN SYNDROME	0.02966099	1.1127661569209777
MENKES DISEASE	0.029075649000000002	1.0908064160270197
15Q13.3 MICRODELETION SYNDROME	0.029075649000000002	1.0908064160270197
BRUCK SYNDROME 2	0.02895166	1.0861548260756904
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.02881992	1.0812124484438996
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901084
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901084
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.02853423	1.0704944594836272
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.02853423	1.0704944594836272
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.02853423	1.0704944594836272
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.02853423	1.0704944594836272
15Q24 RECURRENT MICRODELETION SYNDROME	0.02853423	1.0704944594836272
AASE-SMITH SYNDROME	0.02806349	1.052834106922604
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.02797616	1.0495578215226928
EPILEPSY, PYRIDOXINE-DEPENDENT	0.027795809999999997	1.0427917838280407
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.027795809999999997	1.0427917838280407
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.0421161179623315
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.027777800000000002	1.0421161179623315
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	1.0421161179623315
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.0421161179623315
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.0421161179623315
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.0421161179623315
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.0421161179623315
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	1.0421161179623315
OROFACIAL CLEFT 3	0.027777800000000002	1.0421161179623315
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.0421161179623315
DWARFISM, LEVI TYPE	0.027777800000000002	1.0421161179623315
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.0421161179623315
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.0421161179623315
GANGLIOCYTOMA	0.027777800000000002	1.0421161179623315
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.0421161179623315
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.0421161179623315
NASAL BONES, ABSENCE OF	0.027777800000000002	1.0421161179623315
MENINGIOMA	0.027777800000000002	1.0421161179623315
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.0421161179623315
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.0421161179623315
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.0421161179623315
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623315
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623315
CLEFT CHIN	0.027777800000000002	1.0421161179623315
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.0421161179623315
DIMPLES, FACIAL	0.027777800000000002	1.0421161179623315
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0421161179623315
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.027751730000000002	1.0411380719257382
LOWE OCULOCEREBRORENAL SYNDROME	0.027441269	1.0294907704080263
GAUCHER DISEASE	0.02704185	1.0145061071978223
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668517
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668517
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027027	1.0139489923668517
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668517
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668517
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.02668046	1.000948145664857
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.0265322	0.9953860012312051
XQ21 MICRODELETION SYNDROME	0.026004199	0.9755774363916487
AICARDI-GOUTIÈRES SYNDROME	0.025758469	0.9663585927947157
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.025609730000000004	0.9607784781251022
SAY-BARBER-MILLER SYNDROME	0.025609730000000004	0.9607784781251022
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.025394719000000003	0.9527120931471988
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.025217049999999998	0.9460466362513232
CHROMOSOME 17P13.1 DELETION SYNDROME	0.024853300000000002	0.9324001366038063
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.024853300000000002	0.9324001366038063
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.024853300000000002	0.9324001366038063
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.024853300000000002	0.9324001366038063
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.024853300000000002	0.9324001366038063
TRISOMY 8P	0.024553649	0.9211583846701208
EMANUEL SYNDROME	0.024553649	0.9211583846701208
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.02446062	0.9176682947300276
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.02443564	0.9167311412971894
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024184659999999997	0.9073153379115292
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.02401223	0.9008464281267283
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.02401223	0.9008464281267283
ANE SYNDROME	0.02401223	0.9008464281267283
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.02401223	0.9008464281267283
PMM2-CDG	0.023797219	0.8927800431488251
CLASSIC MULTIMINICORE MYOPATHY	0.0232558	0.8724680866054326
DISTAL MYOTILINOPATHY	0.0232558	0.8724680866054326
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.0232558	0.8724680866054326
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.0232558	0.8724680866054326
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.0232558	0.8724680866054326
BATHING SUIT ICHTHYOSIS	0.0232558	0.8724680866054326
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.0232558	0.8724680866054326
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.0232558	0.8724680866054326
CENTRAL CORE DISEASE	0.0232558	0.8724680866054326
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.0232558	0.8724680866054326
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.0232558	0.8724680866054326
HUNTER-MACDONALD SYNDROME	0.023225720000000002	0.8713396008064024
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.023172469999999997	0.8693418658064562
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.02279455	0.8551637623101276
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.022579539	0.8470973773322242
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.022303729	0.8367500479362611
THROMBOCYTHEMIA, ESSENTIAL	0.02229256	0.8363310300543005
DISTAL TRISOMY 17Q	0.022131149	0.8302755107289249
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.022131149	0.8302755107289249
MOSAIC TRISOMY 15	0.02204909	0.8271969729568958
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.02196765	0.8241416576818613
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8241416576818613
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.02196765	0.8241416576818613
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.02196765	0.8241416576818613
MELAS	0.02196368	0.8239927185654335
OCULOSKELETODENTAL SYNDROME; OCSKD	0.02162906	0.8114390643742247
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.02162906	0.8114390643742247
ISOTRETINOIN-LIKE SYNDROME	0.021589729999999998	0.8099635541855323
ROIFMAN SYNDROME	0.021589729999999998	0.8099635541855323
ROIFMAN SYNDROME; RFMN	0.021589729999999998	0.8099635541855323
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.021589729999999998	0.8099635541855323
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.021589729999999998	0.8099635541855323
ACITRETIN/ETRETINATE EMBRYOPATHY	0.021589729999999998	0.8099635541855323
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.02150999	0.8069720163658953
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.021374719	0.8018971692076293
JERVELL AND LANGE-NIELSEN SYNDROME	0.021374719	0.8018971692076293
DILATED CARDIOMYOPATHY WITH ATAXIA	0.021374719	0.8018971692076293
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.021374719	0.8018971692076293
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.021374719	0.8018971692076293
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.021374719	0.8018971692076293
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.021374719	0.8018971692076293
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.021374719	0.8018971692076293
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.021150289000000003	0.7934774196106748
RENPENNING SYNDROME 1; RENS1	0.021098909	0.7915498398116659
MICROPHTHALMIA, SYNDROMIC 1	0.021098909	0.7915498398116659
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.02100588	0.788059749871573
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0208333	0.7815852126642369
DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	0.0208333	0.7815852126642369
DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101	0.0208333	0.7815852126642369
DEAFNESS, AUTOSOMAL DOMINANT 20	0.0208333	0.7815852126642369
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.0208333	0.7815852126642369
DE BARSY SYNDROME	0.0208333	0.7815852126642369
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.0208333	0.7815852126642369
MEDULLOBLASTOMA	0.0208333	0.7815852126642369
PROTRUSIO ACETABULI	0.0208333	0.7815852126642369
DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY	0.0208333	0.7815852126642369
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.0208333	0.7815852126642369
DEAFNESS, AUTOSOMAL RECESSIVE 94; DFNB94	0.0208333	0.7815852126642369
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.0208333	0.7815852126642369
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0208333	0.7815852126642369
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.0208333	0.7815852126642369
RAMOS-ARROYO SYNDROME	0.0208333	0.7815852126642369
TIETZ SYNDROME	0.0208333	0.7815852126642369
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.0208333	0.7815852126642369
DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37	0.0208333	0.7815852126642369
DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77	0.0208333	0.7815852126642369
N SYNDROME	0.0208333	0.7815852126642369
MYOPATHY, CENTRONUCLEAR, 5	0.0208333	0.7815852126642369
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.0208333	0.7815852126642369
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.0208333	0.7815852126642369
WOODHOUSE-SAKATI SYNDROME	0.0208333	0.7815852126642369
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 11	0.0208333	0.7815852126642369
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0207875	0.7798669729835324
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751291
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751291
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.020740849999999998	0.7781168445751291
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.020669359999999998	0.7754348149949201
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.020614139	0.7733631356628637
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.02055749	0.7712378832682736
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.02055749	0.7712378832682736
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.02055749	0.7712378832682736
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.02055749	0.7712378832682736
MEIER-GORLIN SYNDROME 1; MGORS1	0.02055749	0.7712378832682736
RECOMBINANT CHROMOSOME 8 SYNDROME	0.020342479	0.7631714982903703
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.020342479	0.7631714982903703
611961 STEVENSON-CAREY SYNDROME	0.020342479	0.7631714982903703
FRYNS SYNDROME; FRNS	0.020342479	0.7631714982903703
311450 PALLISTER W SYNDROME;;W SYNDROME	0.020342479	0.7631714982903703
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.020342479	0.7631714982903703
WEAVER SYNDROME	0.020342479	0.7631714982903703
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.020165749	0.7565412690595643
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.01989336	0.7463222824135505
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.019879379000000003	0.7457977691171329
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.019852440000000002	0.7447871215459867
BRACHYDACTYLY, TYPE B1	0.019801060000000002	0.742859541746978
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.019801060000000002	0.742859541746978
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.019801060000000002	0.742859541746978
201020 ACROCEPHALOPOLYSYNDACTYLY TYPE IV;;ACPS IV;;GOODMAN SYNDROME	0.019801060000000002	0.742859541746978
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.019801060000000002	0.742859541746978
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.019801060000000002	0.742859541746978
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.019801060000000002	0.742859541746978
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.019801060000000002	0.742859541746978
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.019801060000000002	0.742859541746978
FIBROCHONDROGENESIS 1; FBCG1	0.019801060000000002	0.742859541746978
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.019801060000000002	0.742859541746978
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.019801060000000002	0.742859541746978
FRONTONASAL DYSPLASIA 1; FND1	0.019801060000000002	0.742859541746978
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.019801060000000002	0.742859541746978
ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	0.019801060000000002	0.742859541746978
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.01974137	0.7406202027395269
HHHH SYNDROME	0.019409319	0.7281629275382687
BAND HETEROTOPIA; BH	0.019409319	0.7281629275382687
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	0.7281629275382687
ATELOSTEOGENESIS TYPE II	0.01933796	0.7254858125737405
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.01933796	0.7254858125737405
SALT-AND-PEPPER SYNDROME	0.01929298	0.7237983361362275
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.01929298	0.7237983361362275
SCHAAF-YANG SYNDROME; SHFYNG	0.018976879000000002	0.7119394435311972
VESICOURETERAL REFLUX 1	0.0188679	0.7078509709948763
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.7078509709948763
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.7078509709948763
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.7078509709948763
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.7078509709948763
VAN DEN BOSCH SYNDROME	0.0188679	0.7078509709948763
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.7078509709948763
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.7078509709948763
TOE, MISSHAPEN	0.0188679	0.7078509709948763
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.7078509709948763
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.7078509709948763
NEPHROSIALIDOSIS	0.0188679	0.7078509709948763
PUBIC BONE DYSPLASIA	0.0188679	0.7078509709948763
SPINAL ARACHNOIDITIS	0.0188679	0.7078509709948763
MEGAEPIPHYSEAL DWARFISM	0.0188679	0.7078509709948763
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.7078509709948763
RAYNAUD DISEASE	0.0188679	0.7078509709948763
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.7078509709948763
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.7078509709948763
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.7078509709948763
TRACHEOBRONCHOMEGALY	0.0188679	0.7078509709948763
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.7078509709948763
LETTERER-SIWE DISEASE	0.0188679	0.7078509709948763
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.7078509709948763
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.7078509709948763
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.7078509709948763
MONOPHALANGY OF GREAT TOE	0.0188679	0.7078509709948763
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.7078509709948763
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.7078509709948763
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.7078509709948763
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.7078509709948763
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0188679	0.7078509709948763
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.7078509709948763
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.7078509709948763
KNUCKLE PADS	0.0188679	0.7078509709948763
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.7078509709948763
THROMBOCYTOPENIA 3	0.0188679	0.7078509709948763
CARPAL DISPLACEMENT	0.0188679	0.7078509709948763
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.7078509709948763
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.7078509709948763
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.7078509709948763
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.018553389999999996	0.6960517665848676
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.01853655	0.6954199946149318
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.0184715	0.6929795690422281
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.01826276	0.6851484478424406
KAPUR-TORIELLO SYNDROME	0.018007309	0.6755649097490857
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.01755391	0.6585551247492655
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.01746589	0.6552529532056932
SYNDACTYLY, TYPE V	0.01746589	0.6552529532056932
FIBROSCLEROSIS, MULTIFOCAL	0.01746589	0.6552529532056932
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.01740912	0.6531231613569247
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397246
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397246
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397246
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6468309526397246
PALMOMENTAL REFLEX	0.0172414	0.6468309526397246
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397246
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397246
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6468309526397246
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397246
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6468309526397246
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397246
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397246
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6468309526397246
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397246
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397246
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397246
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397246
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397246
CERVICAL RIB	0.0172414	0.6468309526397246
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397246
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397246
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397246
TRANSSEXUALITY	0.0172414	0.6468309526397246
DIASTEMATOMYELIA	0.0172414	0.6468309526397246
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6468309526397246
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397246
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397246
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6468309526397246
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6468309526397246
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397246
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397246
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397246
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6468309526397246
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397246
SICKLE CELL ANEMIA	0.0172414	0.6468309526397246
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397246
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6468309526397246
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397246
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397246
RHEUMATOID ARTHRITIS	0.0172414	0.6468309526397246
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397246
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397246
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397246
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6468309526397246
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397246
MOTION SICKNESS	0.0172414	0.6468309526397246
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397246
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397246
AYME-GRIPP SYNDROME; AYGRP	0.017118239	0.6422104260607889
MOSAIC TRISOMY 1	0.01700279	0.6378792240324558
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.01675656	0.6286416223604059
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.01634909	0.6133549166246705
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965498
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965498
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6115698981965498
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
NIEMANN-PICK DISEASE TYPE B	0.016130219999999997	0.6051437568230152
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.016130219999999997	0.6051437568230152
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.016130219999999997	0.6051437568230152
HAREL-YOON SYNDROME; HAYOS	0.016130219999999997	0.6051437568230152
MARINESCO-SJOGREN SYNDROME; MSS	0.01549357	0.5812590997767151
COCKAYNE SYNDROME	0.015462849	0.5801065661253849
WARBURG MICRO SYNDROME 3; WARBM3	0.015278559	0.5731927147988121
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.01499808	0.5626702224974074
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.014996448999999999	0.5626090336563762
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.014925399999999998	0.5599435486984203
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5599435486984203
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.014925399999999998	0.5599435486984203
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984203
MENTAL RETARDATION, X-LINKED 41	0.014925399999999998	0.5599435486984203
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.014925399999999998	0.5599435486984203
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984203
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5599435486984203
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.014918959999999998	0.5597019446909152
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.014903419999999999	0.5591189437162831
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.014878519	0.5581847540593131
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.014830168999999999	0.5563708481955125
CORNELIA DE LANGE SYNDROME 1	0.014697769	0.5514037099045676
BRANCHIOOCULOFACIAL SYNDROME	0.014697769	0.5514037099045676
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.014455029999999999	0.5422970771129837
19P13.3 MICRODUPLICATION SYNDROME	0.014455029999999999	0.5422970771129837
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.014455029999999999	0.5422970771129837
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.014455029999999999	0.5422970771129837
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.0143371	0.5378727975159207
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.0143371	0.5378727975159207
NATIVE AMERICAN MYOPATHY	0.0143371	0.5378727975159207
MOEBIUS SYNDROME; MBS	0.0143371	0.5378727975159207
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.014288750000000001	0.5360588916521202
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2	0.01424165	0.5342918809761117
W SYNDROME	0.01418511	0.5321707178418971
SENGERS SYNDROME	0.01418488	0.5321620891273433
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.013996968999999998	0.5251123918207738
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.013956049000000002	0.5235772309532101
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.013863020000000002	0.5200871410131169
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.013698599999999998	0.513918735591688
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.513918735591688
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.513918735591688
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.013698599999999998	0.513918735591688
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.513918735591688
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.013698599999999998	0.513918735591688
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.513918735591688
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.513918735591688
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.013698599999999998	0.513918735591688
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.013698599999999998	0.513918735591688
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.513918735591688
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.513918735591688
WARBURG MICRO SYNDROME 2; WARBM2	0.01353232	0.5076805501308245
SECKEL SYNDROME 1; SCKL1	0.013492949	0.5062035017799725
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.013492949	0.5062035017799725
DESMOSTEROLOSIS	0.013455549999999998	0.5048004352773815
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.013455549999999998	0.5048004352773815
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.013414630000000002	0.5032652744098176
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.013414630000000002	0.5032652744098176
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.013399920000000001	0.5027134118398795
GAUCHER DISEASE TYPE 2	0.01335762	0.5011264786849929
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.013299779000000001	0.4989565070393242
COFS SYNDROME	0.013299779	0.49895650703932415
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.013199619000000001	0.49519888943191437
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.012951530000000001	0.4858915452365801
ATYPICAL WERNER SYNDROME	0.01285862	0.4824059197183647
SCALP-EAR-NIPPLE SYNDROME; SENS	0.01285862	0.4824059197183647
ALPORT SYNDROME, X-LINKED; ATS	0.01285862	0.4824059197183647
GAUCHER DISEASE TYPE 3	0.01280536	0.4804078095569167
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.01275836	0.4786445504959317
MARDEN-WALKER SYNDROME	0.01275836	0.4786445504959317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.01269912	0.47642209375608585
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.01269912	0.47642209375608585
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.012658200000000001	0.47488693288852196
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.012658200000000001	0.47488693288852196
TIBIAL HEMIMELIA	0.012658200000000001	0.47488693288852196
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.012658200000000001	0.47488693288852196
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.012658200000000001	0.47488693288852196
CONGENITAL PATELLA DISLOCATION	0.012658200000000001	0.47488693288852196
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.012658200000000001	0.47488693288852196
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.012658200000000001	0.47488693288852196
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.012658200000000001	0.47488693288852196
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.012658200000000001	0.47488693288852196
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.012658200000000001	0.47488693288852196
MYOPATHY, DISTAL 3	0.012658200000000001	0.47488693288852196
OTOONYCHOPERONEAL SYNDROME	0.012658200000000001	0.47488693288852196
FINNISH UPPER LIMB-ONSET DISTAL MYOPATHY	0.012658200000000001	0.47488693288852196
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 62	0.012658200000000001	0.47488693288852196
HALLERMANN-STREIFF SYNDROME; HSS	0.01242816	0.46625671768875615
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.01225073	0.4596002271527865
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.01225073	0.4596002271527865
RING CHROMOSOME 14 SYNDROME	0.01225073	0.4596002271527865
BETA-UREIDOPROPIONASE DEFICIENCY	0.01225073	0.4596002271527865
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.01225073	0.4596002271527865
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01225073	0.4596002271527865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.01225073	0.4596002271527865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.01225073	0.4596002271527865
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.01225073	0.4596002271527865
FUMARASE DEFICIENCY; FMRD	0.01225073	0.4596002271527865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.01225073	0.4596002271527865
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.01225073	0.4596002271527865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.01225073	0.4596002271527865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.01225073	0.4596002271527865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.01225073	0.4596002271527865
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.0121951	0.4575132037152844
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.0121951	0.4575132037152844
ACRORENAL-MANDIBULAR SYNDROME	0.0121951	0.4575132037152844
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0121951	0.4575132037152844
PELVISCAPULAR DYSPLASIA	0.0121951	0.4575132037152844
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.0121951	0.4575132037152844
RUIJS-AALFS SYNDROME; RJALS	0.0121951	0.4575132037152844
RARE CIRCULATORY SYSTEM DISEASE	0.0121951	0.4575132037152844
HYPERPROLINEMIA, TYPE I	0.012035718999999999	0.4515338421748833
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.012001930000000001	0.4502662089746361
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.012001930000000001	0.4502662089746361
GERMAN SYNDROME	0.012001930000000001	0.4502662089746361
MOSAIC TRISOMY 8	0.012001930000000001	0.4502662089746361
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.012001930000000001	0.4502662089746361
VICI SYNDROME; VICIS	0.011936629	0.4478163668482236
CROME SYNDROME	0.011936629	0.4478163668482236
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.011865369	0.4451429659825684
MYHRE SYNDROME	0.011865369	0.4451429659825684
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.011494299999999999	0.4312218856314908
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.4312218856314908
WRINKLY SKIN SYNDROME	0.011494299999999999	0.4312218856314908
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.011494299999999999	0.4312218856314908
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.011494299999999999	0.4312218856314908
PEHO-LIKE SYNDROME; PEHOL	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.011494299999999999	0.4312218856314908
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.011494299999999999	0.4312218856314908
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.4312218856314908
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4312218856314908
PERLMAN SYNDROME	0.011494299999999999	0.4312218856314908
PYRIDOXINE-DEPENDENT EPILEPSY	0.011494299999999999	0.4312218856314908
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.011494299999999999	0.4312218856314908
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.4312218856314908
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.011395210000000001	0.42750441030483116
HALLERMANN-STREIFF SYNDROME	0.011395210000000001	0.42750441030483116
ROTHMUND-THOMSON SYNDROME	0.01137533	0.4267585892381847
METATROPIC DYSPLASIA	0.0112926	0.4236548781293487
NEMALINE MYOPATHY 2; NEM2	0.0112926	0.4236548781293487
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.01124122	0.42172729833034
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.01124122	0.42172729833034
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.011180199	0.419438025326928
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.011180199	0.419438025326928
KNOBLOCH SYNDROME 1; KNO1	0.011180199	0.419438025326928
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.010731809	0.4026161587236286
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.010731809	0.4026161587236286
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.010731809	0.4026161587236286
ADAMS-OLIVER SYNDROME 2; AOS2	0.010731809	0.4026161587236286
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.01063878	0.39912606878353546
CATARACT 17, MULTIPLE TYPES	0.01063878	0.39912606878353546
PEROXISOME BIOGENESIS DISORDER 14B	0.01063878	0.39912606878353546
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.01063878	0.39912606878353546
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.01063878	0.39912606878353546
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.01063878	0.39912606878353546
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.01063878	0.39912606878353546
NANCE-HORAN SYNDROME	0.01063878	0.39912606878353546
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.010557109	0.396062087277797
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.01046691	0.3926781680428653
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.01046408	0.392571997337704
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.01019039	0.38230420218023614
WARBURG MICRO SYNDROME 1	0.01019039	0.38230420218023614
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.01019039	0.38230420218023614
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.01019039	0.38230420218023614
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.01019039	0.38230420218023614
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.01019039	0.38230420218023614
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01001569	0.3757501307344046
XQ12-Q13.3 DUPLICATION SYNDROME	0.01001569	0.3757501307344046
PAINE SYNDROME	0.01001569	0.3757501307344046
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.01001569	0.3757501307344046
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01001569	0.3757501307344046
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.01001569	0.3757501307344046
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.01001569	0.3757501307344046
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.009975379	0.3742378172023329
PHACE ASSOCIATION	0.009975379	0.3742378172023329
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.009975379	0.3742378172023329
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.009975379	0.3742378172023329
CODAS SYNDROME	0.009975379	0.3742378172023329
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.009975379	0.3742378172023329
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.009975379	0.3742378172023329
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.36768374575650137
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.36768374575650137
19P13.12 MICRODELETION SYNDROME	0.009696909	0.36379069484674786
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.009696909	0.36379069484674786
HENNEKAM-BEEMER SYNDROME	0.009651639	0.3620923387256672
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.009645529	0.36186311504773916
DUANE RETRACTION SYNDROME	0.009645529	0.36186311504773916
CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES 1	0.00943396	0.35392586065894044
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00943396	0.35392586065894044
CATARACT 7; CTRCT7	0.00943396	0.35392586065894044
49,XYYYY SYNDROME	0.00943396	0.35392586065894044
EDICT SYNDROME	0.00943396	0.35392586065894044
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.00943396	0.35392586065894044
CATARACT, CRYSTALLINE ACULEIFORM	0.00943396	0.35392586065894044
CATARACT 22, MULTIPLE TYPES; CTRCT22	0.00943396	0.35392586065894044
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00943396	0.35392586065894044
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.00943396	0.35392586065894044
CATARACT 15, MULTIPLE TYPES; CTRCT15	0.00943396	0.35392586065894044
%115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	0.00943396	0.35392586065894044
CATARACT, NUCLEAR TOTAL	0.00943396	0.35392586065894044
CATARACT 1, MULTIPLE TYPES	0.00943396	0.35392586065894044
CATARACT, POSTERIOR POLAR, 1 CTPA CATARACT, CONGENITAL TOTAL, INCLUDED	0.00943396	0.35392586065894044
CATARACT 13 WITH ADULT I PHENOTYPE	0.00943396	0.35392586065894044
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 25	0.00943396	0.35392586065894044
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.00943396	0.35392586065894044
CATARACT, CONGENITAL OR JUVENILECATARACT, JUVENILE, HUTTERITE TYPE, INCLUDED	0.00943396	0.35392586065894044
INSULINOMATOSIS AND DIABETES MELLITUS; INSDM	0.00943396	0.35392586065894044
FECHTNER SYNDROME	0.00943396	0.35392586065894044
%614422 CATARACT, CONGENITAL, CERULEAN TYPE, 5; CCA5	0.00943396	0.35392586065894044
PHEOCHROMOCYTOMA	0.00943396	0.35392586065894044
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00943396	0.35392586065894044
HEC SYNDROME	0.00943396	0.35392586065894044
PUPILLARY MEMBRANE, PERSISTENCE OF	0.00943396	0.35392586065894044
SUPERNUMERARY NOSTRIL	0.00943396	0.35392586065894044
CATARACT 3, MULTIPLE TYPES; CTRCT3	0.00943396	0.35392586065894044
RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT	0.00943396	0.35392586065894044
HYDROCEPHALUS, ENDOCARDIAL FIBROELASTOSIS, AND CATARACTS	0.00943396	0.35392586065894044
MUSCULAR HYPERTROPHY-HEPATOMEGALY-POLYHYDRAMNIOS SYNDROME	0.00943396	0.35392586065894044
CATARACT 44; CTRCT44	0.00943396	0.35392586065894044
CONGENITAL FIBRINOGEN DEFICIENCY	0.00943396	0.35392586065894044
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.00943396	0.35392586065894044
CATARACT 45	0.00943396	0.35392586065894044
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00943396	0.35392586065894044
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.00943396	0.35392586065894044
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00925926	0.3473717892131089
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.00925926	0.3473717892131089
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.3473717892131089
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.00925926	0.3473717892131089
HYDROXYLYSINURIA	0.00925926	0.3473717892131089
KRABBE DISEASE	0.00925926	0.3473717892131089
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3473717892131089
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
MERRF	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
CARNOSINEMIA	0.00925926	0.3473717892131089
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.00925926	0.3473717892131089
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.00925926	0.3473717892131089
CARNOSINASE DEFICIENCY	0.00925926	0.3473717892131089
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3473717892131089
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.3473717892131089
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.3473717892131089
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.3473717892131089
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.00925926	0.3473717892131089
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.00925926	0.3473717892131089
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3473717892131089
GLYCINE ENCEPHALOPATHY	0.00925926	0.3473717892131089
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3473717892131089
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.00925926	0.3473717892131089
BIOTINIDASE DEFICIENCY	0.00925926	0.3473717892131089
ROIFMAN-CHITAYAT SYNDROME	0.00925926	0.3473717892131089
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.0090035	0.3377766586293317
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.008940479	0.33541235332545216
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.008940479	0.33541235332545216
CONGENITAL MYASTHENIC SYNDROME	0.008940479	0.33541235332545216
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.008889099	0.33348477352644346
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.008889099	0.33348477352644346
GAUCHER DISEASE, PERINATAL LETHAL	0.008492089	0.3185904867221528
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.008492089	0.3185904867221528
RETT SYNDROME	0.008492089	0.3185904867221528
RFT1-CDG	0.008492089	0.3185904867221528
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.008492089	0.3185904867221528
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.008492089	0.3185904867221528
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.008440709000000001	0.31666290692314414
GLASS SYNDROME	0.008440709000000001	0.31666290692314414
21Q22.11Q22.12 MICRODELETION SYNDROME	0.008440709000000001	0.31666290692314414
BOHRING-OPITZ SYNDROME	0.008440709000000001	0.31666290692314414
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.008440709000000001	0.31666290692314414
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00840089	0.3151690513369874
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.00839906	0.31510039678205976
HURLER SYNDROME	0.00823235	0.30884607937659564
LYNCH SYNDROME	0.008185879	0.3071026663590843
FAMILIAL COLORECTAL CANCER TYPE X	0.008185879	0.3071026663590843
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00795067	0.2982785301787604
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.00795067	0.2982785301787604
RAINE SYNDROME	0.00795067	0.2982785301787604
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.00795067	0.2982785301787604
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.00795067	0.2982785301787604
MECKEL SYNDROME 12; MKS12	0.00795067	0.2982785301787604
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.00795067	0.2982785301787604
NEU-LAXOVA SYNDROME	0.00795067	0.2982785301787604
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.00795067	0.2982785301787604
ADDUCTED THUMBS SYNDROME	0.00795067	0.2982785301787604
GERODERMA OSTEODYSPLASTICUM; GO	0.00789929	0.2963509503797516
OROFACIODIGITAL SYNDROME IX; OFD9	0.00789929	0.2963509503797516
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00789929	0.2963509503797516
CEREBROFACIOARTICULAR SYNDROME	0.00789929	0.2963509503797516
TEEBI-SHALTOUT SYNDROME; TBSH	0.00789929	0.2963509503797516
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.00789929	0.2963509503797516
MEIER-GORLIN SYNDROME 2; MGORS2	0.00789929	0.2963509503797516
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.00779868	0.2925764505047367
1Q44 MICRODELETION SYNDROME	0.00779868	0.2925764505047367
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00779868	0.2925764505047367
AMISH LETHAL MICROCEPHALY	0.00779868	0.2925764505047367
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00779868	0.2925764505047367
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.00779868	0.2925764505047367
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00779868	0.2925764505047367
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.007735659000000001	0.2902121452008572
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.007735659000000001	0.2902121452008572
FETAL GAUCHER DISEASE	0.007735659000000001	0.2902121452008572
1Q21.1 MICRODUPLICATION SYNDROME	0.007735659000000001	0.2902121452008572
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.0076842790000000005	0.28828456540184844
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.0076842790000000005	0.28828456540184844
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0076842790000000005	0.28828456540184844
CATEL-MANZKE SYNDROME; CATMANS	0.0076842790000000005	0.28828456540184844
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.0076842790000000005	0.28828456540184844
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.0076842790000000005	0.28828456540184844
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.0076842790000000005	0.28828456540184844
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.0076842790000000005	0.28828456540184844
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2845100655268335
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2845100655268335
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.00752302	0.28223474853130837
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00752302	0.28223474853130837
WILLIAMS-BEUREN SYNDROME; WBS	0.00752302	0.28223474853130837
ARTERIAL TORTUOSITY SYNDROME	0.00752302	0.28223474853130837
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00752302	0.28223474853130837
BUSCHKE-OLLENDORFF SYNDROME	0.00752302	0.28223474853130837
FABRY DISEASE	0.007512179	0.2818280359466246
TSH-SECRETING PITUITARY ADENOMA	0.007512179	0.2818280359466246
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.007310359	0.2742565265064545
MICROPHTHALMIA, LENZ TYPE	0.007310359	0.2742565265064545
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.007310359	0.2742565265064545
15Q24 MICRODELETION SYNDROME	0.007310359	0.2742565265064545
MOWAT-WILSON SYNDROME	0.007310359	0.2742565265064545
1P36 DELETION SYNDROME	0.007310358999999999	0.27425652650645443
POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA	0.00719424	0.2699001886574647
BRUCK SYNDROME	0.00719424	0.2699001886574647
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00719424	0.2699001886574647
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00719424	0.2699001886574647
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00719424	0.2699001886574647
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00719424	0.2699001886574647
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00719424	0.2699001886574647
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00719424	0.2699001886574647
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00719424	0.2699001886574647
NEMALINE MYOPATHY 10	0.00719424	0.2699001886574647
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.00719424	0.2699001886574647
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00719424	0.2699001886574647
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00719424	0.2699001886574647
INTERMEDIATE NEMALINE MYOPATHY	0.00719424	0.2699001886574647
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00719424	0.2699001886574647
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.00719424	0.2699001886574647
TYPICAL NEMALINE MYOPATHY	0.00719424	0.2699001886574647
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.00719424	0.2699001886574647
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.00719424	0.2699001886574647
LETHAL CONGENITAL CONTRACTURE SYNDROME 2	0.00719424	0.2699001886574647
NEMALINE MYOPATHY 3; NEM3	0.00719424	0.2699001886574647
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00719424	0.2699001886574647
ARTHROGRYPOSIS - HYPERKERATOSIS, LETHAL FORM	0.00719424	0.2699001886574647
NOONAN SYNDROME 2; NS2	0.00719424	0.2699001886574647
MOEBIUS SYNDROME	0.00719424	0.2699001886574647
CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	0.00719424	0.2699001886574647
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.00719424	0.2699001886574647
MULTIMINICORE MYOPATHY	0.00719424	0.2699001886574647
INIENCEPHALY	0.00719424	0.2699001886574647
PELVIC DYSPLASIA - ARTHROGRYPOSIS OF LOWER LIMBS	0.00719424	0.2699001886574647
SPONDYLOSPINAL THORACIC DYSOSTOSIS	0.00719424	0.2699001886574647
NAKAJO-NISHIMURA SYNDROME	0.00719424	0.2699001886574647
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.00719424	0.2699001886574647
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00719424	0.2699001886574647
NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	0.00719424	0.2699001886574647
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.00719424	0.2699001886574647
GERMAN SYNDROME	0.00719424	0.2699001886574647
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.00719424	0.2699001886574647
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00719424	0.2699001886574647
GLYCOGEN STORAGE DISEASE IV	0.00719424	0.2699001886574647
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00719424	0.2699001886574647
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00714286	0.267972608858456
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00714286	0.267972608858456
COHEN-GIBSON SYNDROME; COGIS	0.00714286	0.267972608858456
LOEYS-DIETZ SYNDROME 3; LDS3	0.00714286	0.267972608858456
RAHMAN SYNDROME	0.00714286	0.267972608858456
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00714286	0.267972608858456
WAHAB SYNDROME	0.00714286	0.267972608858456
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00714286	0.267972608858456
20Q11.2 MICRODELETION SYNDROME	0.00714286	0.267972608858456
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.00714286	0.267972608858456
BRITTLE CORNEA SYNDROME	0.00714286	0.267972608858456
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.00714286	0.267972608858456
PSEUDODIASTROPHIC DYSPLASIA	0.00714286	0.267972608858456
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00714286	0.267972608858456
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00714286	0.267972608858456
SILLENCE SYNDROME	0.00714286	0.267972608858456
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.00714286	0.267972608858456
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.00714286	0.267972608858456
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00714286	0.267972608858456
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00714286	0.267972608858456
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00714286	0.267972608858456
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00714286	0.267972608858456
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00714286	0.267972608858456
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.00714286	0.267972608858456
CAMPTOSYNPOLYDACTYLY, COMPLEX	0.00714286	0.267972608858456
MEESTER-LOEYS SYNDROME; MRLS	0.00714286	0.267972608858456
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.00714286	0.267972608858456
13Q12.3 MICRODELETION SYNDROME	0.00714286	0.267972608858456
H SYNDROME	0.00714286	0.267972608858456
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.00714286	0.267972608858456
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.00714286	0.267972608858456
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.00714286	0.267972608858456
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.00704225	0.26419810898344104
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.26419810898344104
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.00704225	0.26419810898344104
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.26419810898344104
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26419810898344104
SARCOSINEMIA	0.00704225	0.26419810898344104
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26419810898344104
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26419810898344104
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.00704225	0.26419810898344104
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.00704225	0.26419810898344104
OROFACIODIGITAL SYNDROME TYPE 2	0.00704225	0.26419810898344104
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.00704225	0.26419810898344104
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26419810898344104
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26419810898344104
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26419810898344104
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.26419810898344104
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.00704225	0.26419810898344104
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.26419810898344104
PELGER-HUET ANOMALY; PHA	0.00704225	0.26419810898344104
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00704225	0.26419810898344104
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00704225	0.26419810898344104
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26419810898344104
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26419810898344104
X SMALL RINGS	0.00704225	0.26419810898344104
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.26419810898344104
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26419810898344104
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.26419810898344104
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.26419810898344104
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26419810898344104
AL AMYLOIDOSIS	0.0069707599999999995	0.26151607940323207
LIDDLE SYNDROME	0.0069707599999999995	0.26151607940323207
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.0069707599999999995	0.26151607940323207
CUSHING SYNDROME	0.0069707599999999995	0.26151607940323207
HEMORRHAGIC FEVER-RENAL SYNDROME	0.0069707599999999995	0.26151607940323207
PERIPARTUM CARDIOMYOPATHY	0.0069707599999999995	0.26151607940323207
SOMATOMAMMOTROPINOMA	0.0069707599999999995	0.26151607940323207
PITUITARY APOPLEXY	0.0069707599999999995	0.26151607940323207
ALPORT SYNDROME	0.0069707599999999995	0.26151607940323207
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.0069707599999999995	0.26151607940323207
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.0069707599999999995	0.26151607940323207
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.0069707599999999995	0.26151607940323207
CLASSICAL EHLERS-DANLOS SYNDROME	0.0069707599999999995	0.26151607940323207
POLYCYTHEMIA VERA	0.0069707599999999995	0.26151607940323207
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.0069707599999999995	0.26151607940323207
CUSHING DISEASE	0.0069707599999999995	0.26151607940323207
CARNEY TRIAD	0.0069707599999999995	0.26151607940323207
ARTERIAL TORTUOSITY SYNDROME	0.0069707599999999995	0.26151607940323207
ACTH-INDEPENDENT CUSHING SYNDROME	0.0069707599999999995	0.26151607940323207
ACTH-DEPENDENT CUSHING SYNDROME	0.0069707599999999995	0.26151607940323207
ACROMEGALY	0.0069707599999999995	0.26151607940323207
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.0069707599999999995	0.26151607940323207
POSTORGASMIC ILLNESS SYNDROME	0.0069707599999999995	0.26151607940323207
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.0069707599999999995	0.26151607940323207
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.006601029	0.2476451956611672
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.006601029	0.2476451956611672
16P13.2 MICRODELETION SYNDROME	0.006601029	0.2476451956611672
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.006601029	0.2476451956611672
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.006601029	0.2476451956611672
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.006601029	0.2476451956611672
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.006601029	0.2476451956611672
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.006601029	0.2476451956611672
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.006553929	0.24587818498515882
GM1 GANGLIOSIDOSIS	0.006553929	0.24587818498515882
OCULODENTODIGITAL DYSPLASIA	0.006553929	0.24587818498515882
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.006105539	0.22905631838185941
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.006105539	0.22905631838185941
6Q25 MICRODELETION SYNDROME	0.006105539	0.22905631838185941
2Q31.1 MICRODELETION SYNDROME	0.006105539	0.22905631838185941
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.006105539	0.22905631838185941
ATYPICAL RETT SYNDROME	0.006105539	0.22905631838185941
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.006105539	0.22905631838185941
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.006105539	0.22905631838185941
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.006105539	0.22905631838185941
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.006105539	0.22905631838185941
GALLOWAY-MOWAT SYNDROME	0.006105539	0.22905631838185941
BOHRING-OPITZ SYNDROME	0.006105539	0.22905631838185941
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.006105539	0.22905631838185941
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.006105539	0.22905631838185941
HEART AND BRAIN MALFORMATION SYNDROME	0.006105539	0.22905631838185941
COG5-CDG	0.006105539	0.22905631838185941
MACDERMOT-WINTER SYNDROME	0.006105539	0.22905631838185941
DISTAL TRISOMY 15Q	0.006105539	0.22905631838185941
BOWEN-CONRADI SYNDROME	0.006105539	0.22905631838185941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.006059609999999999	0.22733323911777473
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.006059609999999999	0.22733323911777473
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.006059609999999999	0.22733323911777473
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.006059609999999999	0.22733323911777473
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.0060125099999999996	0.22556622844176633
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.005927328999999999	0.22237056524870752
COCKAYNE SYNDROME A; CSA	0.005927328999999999	0.22237056524870752
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.005844599	0.21926685413987154
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.005844599	0.21926685413987154
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.005844599	0.21926685413987154
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.005844599	0.21926685413987154
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.005844599	0.21926685413987154
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.005844599	0.21926685413987154
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.005844599	0.21926685413987154
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.005844599	0.21926685413987154
2P15P16.1 MICRODELETION SYNDROME	0.00556412	0.20874436183846695
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00556412	0.20874436183846695
8Q22.1 MICRODELETION SYNDROME	0.00556412	0.20874436183846695
PENTASOMY X	0.00556412	0.20874436183846695
SHPRINTZEN-GOLDBERG SYNDROME	0.00556412	0.20874436183846695
2P15-16.1 MICRODELETION SYNDROME	0.00556412	0.20874436183846695
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.00556412	0.20874436183846695
WAARDENBURG SYNDROME TYPE 3	0.00556412	0.20874436183846695
TRISOMY 4P	0.00556412	0.20874436183846695
EAR-PATELLA-SHORT STATURE SYNDROME	0.00556412	0.20874436183846695
MOSAIC TRISOMY 9	0.00556412	0.20874436183846695
CRANIOFRONTONASAL DYSPLASIA	0.00556412	0.20874436183846695
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00556412	0.20874436183846695
OROFACIODIGITAL SYNDROME TYPE 4	0.00556412	0.20874436183846695
FAMILIAL VISCERAL MYOPATHY	0.00556412	0.20874436183846695
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00556412	0.20874436183846695
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00556412	0.20874436183846695
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00556412	0.20874436183846695
TRISOMY 18	0.00556412	0.20874436183846695
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00556412	0.20874436183846695
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.005396209	0.20244498753657214
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.005396209	0.20244498753657214
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.005396209	0.20244498753657214
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.005396209	0.20244498753657214
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.005396209	0.20244498753657214
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.005396209	0.20244498753657214
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.005396209	0.20244498753657214
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.005396209	0.20244498753657214
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.005396209	0.20244498753657214
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.005396209	0.20244498753657214
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.005396209	0.20244498753657214
KEPPEN-LUBINSKY SYNDROME	0.005396209	0.20244498753657214
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.005396209	0.20244498753657214
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.005396209	0.20244498753657214
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.005396209	0.20244498753657214
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.005396209	0.20244498753657214
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.005396209	0.20244498753657214
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.005396208999999999	0.2024449875365721
INCONTINENTIA PIGMENTI	0.0053491089999999995	0.20067797686056377
HENNEKAM SYNDROME	0.0053491089999999995	0.20067797686056377
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.0053491089999999995	0.20067797686056377
RECOMBINANT 8 SYNDROME	0.0053491089999999995	0.20067797686056377
ACROCARDIOFACIAL SYNDROME	0.0053491089999999995	0.20067797686056377
INTELLECTUAL DISABILITY, WOLFF TYPE	0.0053491089999999995	0.20067797686056377
MOSAIC TRISOMY 14	0.0053491089999999995	0.20067797686056377
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.0053491089999999995	0.20067797686056377
SIMPSON-GOLABI-BEHMEL SYNDROME	0.0053491089999999995	0.20067797686056377
2Q24 MICRODELETION SYNDROME	0.0053491089999999995	0.20067797686056377
CRISPONI SYNDROME	0.0053491089999999995	0.20067797686056377
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.0053491089999999995	0.20067797686056377
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.005303179999999999	0.19895489759647905
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.005303179999999999	0.19895489759647905
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.005303179999999999	0.19895489759647905
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.005303179999999999	0.19895489759647905
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.005303179999999999	0.19895489759647905
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.005303179999999999	0.19895489759647905
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.005303179999999999	0.19895489759647905
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.005303179999999999	0.19895489759647905
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.005303179999999999	0.19895489759647905
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.005303179999999999	0.19895489759647905
TETRASOMY 9P	0.005292339	0.1985481850117953
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.005292339	0.1985481850117953
CHOREOACANTHOCYTOSIS	0.005292339	0.1985481850117953
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.005292339	0.1985481850117953
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.005292339	0.1985481850117953
ALEXANDER DISEASE	0.005170899	0.19399222372741184
POTOCKI-SHAFFER SYNDROME	0.005170899	0.19399222372741184
COACH SYNDROME	0.005170899	0.19399222372741184
ALLAN-HERNDON-DUDLEY SYNDROME	0.0048547899999999995	0.18213303099317968
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.0048547899999999995	0.18213303099317968
JACOBSEN SYNDROME	0.0048547899999999995	0.18213303099317968
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.0048547899999999995	0.18213303099317968
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.0048547899999999995	0.18213303099317968
AICARDI-GOUTIERES SYNDROME 5	0.0048547899999999995	0.18213303099317968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.0048547899999999995	0.18213303099317968
TRISOMY 17P	0.0048547899999999995	0.18213303099317968
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.0048547899999999995	0.18213303099317968
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.0048547899999999995	0.18213303099317968
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.0048547899999999995	0.18213303099317968
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.0048547899999999995	0.18213303099317968
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.0048547899999999995	0.18213303099317968
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.0048547899999999995	0.18213303099317968
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0048547899999999995	0.18213303099317968
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0048547899999999995	0.18213303099317968
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.0048547899999999995	0.18213303099317968
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.004843949	0.1817263184084959
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.004843949	0.1817263184084959
XERODERMA PIGMENTOSUM	0.004843949	0.1817263184084959
MENKES DISEASE	0.004843949	0.1817263184084959
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.004843949	0.1817263184084959
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.004843948999999999	0.18172631840849585
FRONTONASAL DYSPLASIA	0.00480769	0.1803660203171713
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.00480769	0.1803660203171713
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00480769	0.1803660203171713
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00480769	0.1803660203171713
FIBROCHONDROGENESIS	0.00480769	0.1803660203171713
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00480769	0.1803660203171713
SPONDYLOCAMPTODACTYLY SYNDROME	0.00480769	0.1803660203171713
8Q21.11 MICRODELETION SYNDROME	0.00480769	0.1803660203171713
ENG-STROM SYNDROME	0.00480769	0.1803660203171713
MASA SYNDROME	0.00480769	0.1803660203171713
ACROPECTOROVERTEBRAL DYSPLASIA	0.00480769	0.1803660203171713
AARSKOG-SCOTT SYNDROME	0.00480769	0.1803660203171713
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	0.00480769	0.1803660203171713
FRANK-TER HAAR SYNDROME	0.00480769	0.1803660203171713
CATEL-MANZKE SYNDROME	0.00480769	0.1803660203171713
PELVIS-SHOULDER DYSPLASIA	0.00480769	0.1803660203171713
HEREDITARY ACROKERATOTIC POIKILODERMA	0.00480769	0.1803660203171713
PHAVER SYNDROME	0.00480769	0.1803660203171713
INFANTILE SYSTEMIC HYALINOSIS	0.00480769	0.1803660203171713
CAMPTOBRACHYDACTYLY	0.00480769	0.1803660203171713
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00480769	0.1803660203171713
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.00480769	0.1803660203171713
OTOPALATODIGITAL SYNDROME TYPE 2	0.00480769	0.1803660203171713
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.00480769	0.1803660203171713
LOEYS-DIETZ SYNDROME	0.00480769	0.1803660203171713
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.00480769	0.1803660203171713
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00480769	0.1803660203171713
ALLAN-HERNDON-DUDLEY SYNDROME	0.00480769	0.1803660203171713
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00480769	0.1803660203171713
15Q26 OVERGROWTH SYNDROME	0.00480769	0.1803660203171713
MUCKLE-WELLS SYNDROME	0.00480769	0.1803660203171713
ABLEPHARON MACROSTOMIA SYNDROME	0.00480769	0.1803660203171713
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00480769	0.1803660203171713
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.00480769	0.1803660203171713
FLOATING-HARBOR SYNDROME	0.00480769	0.1803660203171713
DIGITAL EXTENSOR MUSCLE APLASIA-POLYNEUROPATHY	0.00480769	0.1803660203171713
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.00480769	0.1803660203171713
KINDLER SYNDROME	0.00480769	0.1803660203171713
SYNDACTYLY TYPE 2	0.00480769	0.1803660203171713
FOCAL DERMAL HYPOPLASIA	0.00480769	0.1803660203171713
SYNDACTYLY TYPE 3	0.00480769	0.1803660203171713
COOPER-JABS SYNDROME	0.00480769	0.1803660203171713
ULNAR-MAMMARY SYNDROME	0.00480769	0.1803660203171713
LERI PLEONOSTEOSIS	0.00480769	0.1803660203171713
SYNDACTYLY TYPE 4	0.00480769	0.1803660203171713
SYNDACTYLY TYPE 5	0.00480769	0.1803660203171713
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.00480769	0.1803660203171713
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00480769	0.1803660203171713
FREEMAN-SHELDON SYNDROME	0.00480769	0.1803660203171713
MICROPHTHALMIA-MICROTIA-FETAL AKINESIA SYNDROME	0.00480769	0.1803660203171713
DIASTROPHIC DWARFISM	0.00480769	0.1803660203171713
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00480769	0.1803660203171713
MESOMELIC LIMB SHORTENING AND BOWING	0.00480769	0.1803660203171713
SPONDYLOCAMPTODACTYLY	0.00480769	0.1803660203171713
DIGITOTALAR DYSMORPHISM	0.00480769	0.1803660203171713
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.00480769	0.1803660203171713
FRONTOMETAPHYSEAL DYSPLASIA	0.00480769	0.1803660203171713
EXTENSOR TENDONS OF FINGER ANOMALIES	0.00480769	0.1803660203171713
CAMPTODACTYLY 1; CAMPD1	0.00480769	0.1803660203171713
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00480769	0.1803660203171713
GORDON SYNDROME	0.00480769	0.1803660203171713
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00480769	0.1803660203171713
16P11.2P12.2 MICRODELETION SYNDROME	0.00480769	0.1803660203171713
HYPERTRYPTOPHANEMIA; HYPTRP	0.00480769	0.1803660203171713
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00480769	0.1803660203171713
HYPOPLASTIC TIBIAE-POSTAXIAL POLYDACTYLY SYNDROME	0.00480769	0.1803660203171713
FRONTORHINY	0.00480769	0.1803660203171713
OPHTHALMOMANDIBULOMELIC DYSPLASIA	0.00480769	0.1803660203171713
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00480769	0.1803660203171713
TRISOMY 1Q	0.00480769	0.1803660203171713
DISTAL SYMPHALANGISM	0.00480769	0.1803660203171713
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.00480769	0.1803660203171713
ANTLEY-BIXLER SYNDROME	0.00480769	0.1803660203171713
THORACO-ABDOMINAL ENTERIC DUPLICATION	0.00480769	0.1803660203171713
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00480769	0.1803660203171713
DESBUQUOIS SYNDROME	0.00480769	0.1803660203171713
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00480769	0.1803660203171713
TRISOMY 20P	0.00480769	0.1803660203171713
ECTRODACTYLY-POLYDACTYLY SYNDROME	0.00480769	0.1803660203171713
CAMPTODACTYLY-TALL STATURE-SCOLIOSIS-HEARING LOSS SYNDROME	0.00480769	0.1803660203171713
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.00480769	0.1803660203171713
ABSENCE OF FINGERPRINTS-CONGENITAL MILIA SYNDROME	0.00480769	0.1803660203171713
WEAVER SYNDROME	0.00480769	0.1803660203171713
METATROPIC DYSPLASIA	0.00480769	0.1803660203171713
SUMMITT SYNDROME	0.00480769	0.1803660203171713
DIGITOTALAR DYSMORPHISM	0.00480769	0.1803660203171713
TRISOMY 8Q	0.00480769	0.1803660203171713
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.00480769	0.1803660203171713
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.00480769	0.1803660203171713
DISTAL TRISOMY 18Q	0.00480769	0.1803660203171713
MESOMELIC DWARFISM-CLEFT PALATE-CAMPTODACTYLY SYNDROME	0.00480769	0.1803660203171713
PROXIMAL SYMPHALANGISM	0.00480769	0.1803660203171713
ERDHEIM-CHESTER DISEASE	0.00475092	0.17823622846840279
GIANT CELL ARTERITIS	0.00475092	0.17823622846840279
HERMANSKY-PUDLAK SYNDROME	0.00475092	0.17823622846840279
ADAMS-OLIVER SYNDROME 1; AOS1	0.004722509	0.17717035712411247
OROFACIODIGITAL SYNDROME I; OFD1	0.004722509	0.17717035712411247
PRADER-WILLI-LIKE SYNDROME	0.004639779	0.17406664601527652
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.004639779	0.17406664601527652
MUCOPOLYSACCHARIDOSIS, TYPE II	0.004639779	0.17406664601527652
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.004639779	0.17406664601527652
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.004639779	0.17406664601527652
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.004639779	0.17406664601527652
KAGAMI-OGATA SYNDROME	0.004639779	0.17406664601527652
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.004639779	0.17406664601527652
PETTIGREW SYNDROME	0.004639779	0.17406664601527652
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.004639779	0.17406664601527652
CANAVAN DISEASE	0.004639779	0.17406664601527652
ZTTK SYNDROME; ZTTKS	0.004639779	0.17406664601527652
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.004639779	0.17406664601527652
GLUTAMINE DEFICIENCY, CONGENITAL	0.004639779	0.17406664601527652
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.004639779	0.17406664601527652
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.004639779	0.17406664601527652
PALLISTER-KILLIAN SYNDROME	0.004639779	0.17406664601527652
HUNTINGTON DISEASE-LIKE 3	0.004639779	0.17406664601527652
SIALIDOSIS TYPE 2	0.004639779	0.17406664601527652
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.004639779	0.17406664601527652
JOUBERT SYNDROME 14	0.00462948	0.17368026718401938
ISOLATED ECTOPIA LENTIS	0.00462948	0.17368026718401938
BARDET-BIEDL SYNDROME 1; BBS1	0.00462948	0.17368026718401938
ALSTROM SYNDROME; ALMS	0.00462948	0.17368026718401938
VON HIPPEL-LINDAU DISEASE	0.00462948	0.17368026718401938
BARDET-BIEDL SYNDROME	0.00462948	0.17368026718401938
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.00418109	0.15685840058072
XFE PROGEROID SYNDROME; XFEPS	0.00418109	0.15685840058072
MONOSOMY 18P	0.00418109	0.15685840058072
SECKEL SYNDROME 10; SCKL10	0.00418109	0.15685840058072
PEDIATRIC-ONSET GRAVES DISEASE	0.00418109	0.15685840058072
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00409836	0.15375468947188403
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.00409836	0.15375468947188403
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00409836	0.15375468947188403
RESTRICTIVE DERMOPATHY, LETHAL	0.00409836	0.15375468947188403
NEONATAL MARFAN SYNDROME	0.00409836	0.15375468947188403
DRACUNCULIASIS	0.00409836	0.15375468947188403
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.00409836	0.15375468947188403
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.00409836	0.15375468947188403
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00409836	0.15375468947188403
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00409836	0.15375468947188403
HYPERMANGANESEMIA WITH DYSTONIA 2	0.00409836	0.15375468947188403
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.00409836	0.15375468947188403
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.00409836	0.15375468947188403
MAJEED SYNDROME	0.00409836	0.15375468947188403
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.00409836	0.15375468947188403
NEMALINE MYOPATHY 1; NEM1	0.00409836	0.15375468947188403
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.00409836	0.15375468947188403
NEMALINE MYOPATHY 4	0.00409836	0.15375468947188403
GROWTH FACTORS, COMBINED DEFECT OF	0.00409836	0.15375468947188403
CZECH DYSPLASIA, METATARSAL TYPE	0.00409836	0.15375468947188403
268650 RUDIGER SYNDROME	0.00409836	0.15375468947188403
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00409836	0.15375468947188403
ANAUXETIC DYSPLASIA 2; ANXD2	0.00409836	0.15375468947188403
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.00409836	0.15375468947188403
CHRONIC GRAFT VERSUS HOST DISEASE	0.00409836	0.15375468947188403
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00409836	0.15375468947188403
HYPERKALEMIC PERIODIC PARALYSIS	0.00409836	0.15375468947188403
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00409836	0.15375468947188403
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00409836	0.15375468947188403
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00409836	0.15375468947188403
ICHTHYOSIS HYSTRIX OF CURTH-MACKLIN	0.00409836	0.15375468947188403
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00409836	0.15375468947188403
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.00409836	0.15375468947188403
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00409836	0.15375468947188403
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.00409836	0.15375468947188403
MAJEED SYNDROME	0.00409836	0.15375468947188403
TEMPLE SYNDROME	0.00409836	0.15375468947188403
MECKEL SYNDROME 13; MKS13	0.00409836	0.15375468947188403
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1	0.00409836	0.15375468947188403
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.00409836	0.15375468947188403
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.00409836	0.15375468947188403
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.00409836	0.15375468947188403
DUCHENNE MUSCULAR DYSTROPHY	0.00409836	0.15375468947188403
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.00409836	0.15375468947188403
CUTIS LAXA-MARFANOID SYNDROME	0.00409836	0.15375468947188403
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B	0.00409836	0.15375468947188403
AASE-SMITH SYNDROME I	0.00409836	0.15375468947188403
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.00409836	0.15375468947188403
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.00409836	0.15375468947188403
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00409836	0.15375468947188403
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00409836	0.15375468947188403
MARFAN SYNDROME; MFS	0.00409836	0.15375468947188403
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00409836	0.15375468947188403
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.00409836	0.15375468947188403
HURLER SYNDROME	0.00409836	0.15375468947188403
SALIH MYOPATHY; SALMY	0.00409836	0.15375468947188403
CHST3-RELATED SKELETAL DYSPLASIA	0.00409836	0.15375468947188403
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00409836	0.15375468947188403
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00409836	0.15375468947188403
STIFF SKIN SYNDROME	0.00409836	0.15375468947188403
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00409836	0.15375468947188403
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.00409836	0.15375468947188403
ORAL SUBMUCOUS FIBROSIS	0.00409836	0.15375468947188403
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00409836	0.15375468947188403
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00409836	0.15375468947188403
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00409836	0.15375468947188403
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.00409836	0.15375468947188403
BUSCHKE-OLLENDORFF SYNDROME; BOS	0.00409836	0.15375468947188403
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00409836	0.15375468947188403
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00409836	0.15375468947188403
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00409836	0.15375468947188403
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00409836	0.15375468947188403
ADULT-ONSET NEMALINE MYOPATHY	0.00409836	0.15375468947188403
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00409836	0.15375468947188403
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00409836	0.15375468947188403
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00409836	0.15375468947188403
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.00409836	0.15375468947188403
BASAN SYNDROME	0.00409836	0.15375468947188403
POTASSIUM-AGGRAVATED MYOTONIA	0.00409836	0.15375468947188403
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.00409836	0.15375468947188403
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.0040875189999999995	0.15334797688720023
ATYPICAL JUVENILE PARKINSONISM	0.0040875189999999995	0.15334797688720023
ADDISON DISEASE	0.0040875189999999995	0.15334797688720023
SPONTANEOUS PERIODIC HYPOTHERMIA	0.0040875189999999995	0.15334797688720023
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0040875189999999995	0.15334797688720023
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.0040875189999999995	0.15334797688720023
LASSA FEVER	0.0040875189999999995	0.15334797688720023
BENIGN FAMILIAL INFANTILE EPILEPSY	0.0040875189999999995	0.15334797688720023
NIPAH VIRUS DISEASE	0.0040875189999999995	0.15334797688720023
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.0040875189999999995	0.15334797688720023
WHIPPLE DISEASE	0.0040875189999999995	0.15334797688720023
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.0040875189999999995	0.15334797688720023
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.0040875189999999995	0.15334797688720023
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.0040875189999999995	0.15334797688720023
VIRAL HEMORRHAGIC FEVER	0.0040875189999999995	0.15334797688720023
BEHÇET DISEASE	0.0040875189999999995	0.15334797688720023
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.0040875189999999995	0.15334797688720023
GITELMAN SYNDROME	0.0040875189999999995	0.15334797688720023
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.0040875189999999995	0.15334797688720023
RIFT VALLEY FEVER	0.0040875189999999995	0.15334797688720023
EBOLA HEMORRHAGIC FEVER	0.0040875189999999995	0.15334797688720023
ACUTE ADRENAL INSUFFICIENCY	0.0040875189999999995	0.15334797688720023
ADIPOSIS DOLOROSA	0.0040875189999999995	0.15334797688720023
MALIGNANT ATROPHIC PAPULOSIS	0.0040875189999999995	0.15334797688720023
LYMPHANGIOLEIOMYOMATOSIS	0.0040875189999999995	0.15334797688720023
NON-FUNCTIONING PITUITARY ADENOMA	0.0040875189999999995	0.15334797688720023
INSULINOMA	0.0040875189999999995	0.15334797688720023
ACQUIRED METHEMOGLOBINEMIA	0.0040875189999999995	0.15334797688720023
SYSTEMIC SCLEROSIS	0.0040875189999999995	0.15334797688720023
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.0040875189999999995	0.15334797688720023
CRONKHITE-CANADA SYNDROME	0.0040875189999999995	0.15334797688720023
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.0040875189999999995	0.15334797688720023
TAKAYASU ARTERITIS	0.0040875189999999995	0.15334797688720023
PROLACTINOMA	0.0040875189999999995	0.15334797688720023
LUJO HEMORRHAGIC FEVER	0.0040875189999999995	0.15334797688720023
NOCARDIOSIS	0.0040875189999999995	0.15334797688720023
GLIOBLASTOMA	0.0040875189999999995	0.15334797688720023
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.0040875189999999995	0.15334797688720023
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.0040875189999999995	0.15334797688720023
MIXED CONNECTIVE TISSUE DISEASE	0.0040875189999999995	0.15334797688720023
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.0040875189999999995	0.15334797688720023
MERCURY POISONING	0.003966079	0.14879201560281682
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.003966079	0.14879201560281682
SNEDDON SYNDROME	0.003966079	0.14879201560281682
KEUTEL SYNDROME; KTLS	0.003966079	0.14879201560281682
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.003966079	0.14879201560281682
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.003966079	0.14879201560281682
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.003966079	0.14879201560281682
PRADER-WILLI SYNDROME	0.003966079	0.14879201560281682
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.003966079	0.14879201560281682
FAMILIAL DYSAUTONOMIA	0.003966079	0.14879201560281682
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.003966079	0.14879201560281682
NEUROFIBROMATOSIS, TYPE I	0.003966079	0.14879201560281682
CLASSIC HOMOCYSTINURIA	0.003966079	0.14879201560281682
OROFACIODIGITAL SYNDROME TYPE 1	0.003966079	0.14879201560281682
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.003966079	0.14879201560281682
NEUROFIBROMATOSIS TYPE 1	0.003966079	0.14879201560281682
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.003966079	0.14879201560281682
SNEDDON SYNDROME	0.003966079	0.14879201560281682
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.003966079	0.14879201560281682
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.003966079	0.14879201560281682
CADASIL	0.003966079	0.14879201560281682
PREECLAMPSIA/ECLAMPSIA 1	0.003966079	0.14879201560281682
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.003966079	0.14879201560281682
BETA-KETOTHIOLASE DEFICIENCY	0.003966079	0.14879201560281682
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.003966079	0.14879201560281682
AUTOIMMUNE HEMOLYTIC ANEMIA	0.0035461	0.13303602034380776
PONTIAC FEVER	0.0035461	0.13303602034380776
EISENMENGER SYNDROME	0.0035461	0.13303602034380776
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 37	0.0035461	0.13303602034380776
PRIMARY FAMILIAL POLYCYTHEMIA	0.0035461	0.13303602034380776
DUBIN-JOHNSON SYNDROME	0.0035461	0.13303602034380776
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.0035461	0.13303602034380776
DERMATOMYOSITIS	0.0035461	0.13303602034380776
THYMOMA	0.0035461	0.13303602034380776
RARE HEREDITARY HEMOCHROMATOSIS	0.0035461	0.13303602034380776
KAWASAKI DISEASE	0.0035461	0.13303602034380776
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.0035461	0.13303602034380776
HODGKIN LYMPHOMA	0.0035461	0.13303602034380776
MASTOCYTOSIS	0.0035461	0.13303602034380776
CRYPTOGENIC ORGANIZING PNEUMONIA	0.0035461	0.13303602034380776
LYME DISEASE	0.0035461	0.13303602034380776
TYPHOID	0.0035461	0.13303602034380776
BABESIOSIS	0.0035461	0.13303602034380776
RELAPSING FEVER	0.0035461	0.13303602034380776
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.0035461	0.13303602034380776
MARBURG HEMORRHAGIC FEVER	0.0035461	0.13303602034380776
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.0035461	0.13303602034380776
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.0035461	0.13303602034380776
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, MYOPATHIC FORM	0.0035461	0.13303602034380776
AUTOIMMUNE HEMOLYTIC ANEMIA, COLD TYPE	0.0035461	0.13303602034380776
BECKER MUSCULAR DYSTROPHY	0.0035461	0.13303602034380776
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.0035461	0.13303602034380776
ISOLATED AGAMMAGLOBULINEMIA	0.0035461	0.13303602034380776
REYNOLDS SYNDROME	0.0035461	0.13303602034380776
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.0035461	0.13303602034380776
PERIPHERAL HYPOTHYROIDISM	0.0035461	0.13303602034380776
PANHYPOPITUITARISM	0.0035461	0.13303602034380776
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.0035461	0.13303602034380776
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.0035461	0.13303602034380776
FUNCTIONING GONADOTROPIC ADENOMA	0.0035461	0.13303602034380776
CREATINE PHOSPHOKINASE, ELEVATED SERUM	0.0035461	0.13303602034380776
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.0035461	0.13303602034380776
UNCLASSIFIED MYELODYSPLASTIC SYNDROME	0.0035461	0.13303602034380776
CENTRAL CONGENITAL HYPOTHYROIDISM	0.0035461	0.13303602034380776
AREGENERATIVE ANEMIA	0.0035461	0.13303602034380776
CLASSIC HODGKIN LYMPHOMA	0.0035461	0.13303602034380776
GAMMA-HEAVY CHAIN DISEASE	0.0035461	0.13303602034380776
PRIMARY SCLEROSING CHOLANGITIS	0.0035461	0.13303602034380776
WISKOTT-ALDRICH SYNDROME	0.0035461	0.13303602034380776
REFRACTORY ANEMIA	0.0035461	0.13303602034380776
ANISOCORIA	0.0035461	0.13303602034380776
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.0035461	0.13303602034380776
CYSTINOSIS	0.0035461	0.13303602034380776
CASTLEMAN DISEASE	0.0035461	0.13303602034380776
GENETIC HYPERFERRITINEMIA WITHOUT IRON OVERLOAD	0.0035461	0.13303602034380776
EVANS SYNDROME	0.0035461	0.13303602034380776
ADIPOSIS DOLOROSA	0.0035461	0.13303602034380776
IATROGENIC BOTULISM	0.0035461	0.13303602034380776
PARATHYROID CARCINOMA	0.0035461	0.13303602034380776
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.0035461	0.13303602034380776
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.0035461	0.13303602034380776
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.0035461	0.13303602034380776
INHALATIONAL BOTULISM	0.0035461	0.13303602034380776
THYROID HYPOPLASIA	0.0035461	0.13303602034380776
THYROID HEMIAGENESIS	0.0035461	0.13303602034380776
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.0035461	0.13303602034380776
ACUTE PANMYELOSIS WITH MYELOFIBROSIS	0.0035461	0.13303602034380776
FAMILIAL THYROID DYSHORMONOGENESIS	0.0035461	0.13303602034380776
ATHYREOSIS	0.0035461	0.13303602034380776
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.0035461	0.13303602034380776
CINCA SYNDROME	0.0035461	0.13303602034380776
HUGHES-STOVIN SYNDROME	0.0035461	0.13303602034380776
ARACHNOIDITIS	0.0035461	0.13303602034380776
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.0035461	0.13303602034380776
CONGENITAL ANALBUMINEMIA	0.0035461	0.13303602034380776
PITUICYTOMA	0.0035461	0.13303602034380776
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.0035461	0.13303602034380776
NEUROLEPTIC MALIGNANT SYNDROME	0.0035461	0.13303602034380776
HEPATOCELLULAR CARCINOMA	0.0035461	0.13303602034380776
NON-FUNCTIONING PARAGANGLIOMA	0.0035461	0.13303602034380776
POST-TRAUMATIC PITUITARY DEFICIENCY	0.0035461	0.13303602034380776
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.0035461	0.13303602034380776
AMYOTROPHIC LATERAL SCLEROSIS	0.0035461	0.13303602034380776
HYPOTONIA-CYSTINURIA SYNDROME	0.0035461	0.13303602034380776
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.0035461	0.13303602034380776
PULMONARY ARTERIAL HYPERTENSION	0.0035461	0.13303602034380776
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.0035461	0.13303602034380776
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.0035461	0.13303602034380776
BOTULISM	0.0035461	0.13303602034380776
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.0035461	0.13303602034380776
PRIMARY MYELOFIBROSIS	0.0035461	0.13303602034380776
JUVENILE DERMATOMYOSITIS	0.0035461	0.13303602034380776
ADULT-ONSET STILL DISEASE	0.0035461	0.13303602034380776
PRIMARY BILIARY CHOLANGITIS	0.0035461	0.13303602034380776
SYSTEMIC CAPILLARY LEAK SYNDROME	0.0035461	0.13303602034380776
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.0035461	0.13303602034380776
EBSTEIN MALFORMATION	0.0035461	0.13303602034380776
HELLP SYNDROME	0.0035461	0.13303602034380776
BLACKFAN-DIAMOND ANEMIA	0.0035461	0.13303602034380776
THYMIC CARCINOMA	0.0035461	0.13303602034380776
PRIMARY PARATHYROID HYPERPLASIA	0.0035461	0.13303602034380776
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.0035461	0.13303602034380776
KLATSKIN TUMOR	0.0035461	0.13303602034380776
PYOGENIC ARTHRITIS-PYODERMA GANGRENOSUM-ACNE SYNDROME	0.0035461	0.13303602034380776
MUCOLIPIDOSIS TYPE III	0.0035461	0.13303602034380776
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.0035461	0.13303602034380776
MANTLE CELL LYMPHOMA	0.0035461	0.13303602034380776
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.0035461	0.13303602034380776
POEMS SYNDROME	0.0035461	0.13303602034380776
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.0035461	0.13303602034380776
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.0035461	0.13303602034380776
MULTIPLE MYELOMA	0.0035461	0.13303602034380776
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.0035461	0.13303602034380776
MACROPHAGIC MYOFASCIITIS	0.0035461	0.13303602034380776
EOSINOPHILIC FASCIITIS	0.0035461	0.13303602034380776
STEVENS-JOHNSON SYNDROME	0.0035461	0.13303602034380776
CHRONIC MYELOID LEUKEMIA	0.0035461	0.13303602034380776
ACUTE PROMYELOCYTIC LEUKEMIA	0.0035461	0.13303602034380776
LEGIONELLOSIS	0.0035461	0.13303602034380776
X-LINKED AGAMMAGLOBULINEMIA	0.0035461	0.13303602034380776
LIPOSARCOMA	0.0035461	0.13303602034380776
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.0035461	0.13303602034380776
CUTANEOUS MASTOCYTOSIS	0.0035461	0.13303602034380776
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.0035461	0.13303602034380776
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.0035461	0.13303602034380776
PLAGUE	0.0035461	0.13303602034380776
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.0035461	0.13303602034380776
WALDENSTRÖM MACROGLOBULINEMIA	0.0035461	0.13303602034380776
AUTOSOMAL AGAMMAGLOBULINEMIA	0.0035461	0.13303602034380776
MALT LYMPHOMA	0.0035461	0.13303602034380776
COLD AGGLUTININ DISEASE	0.0035461	0.13303602034380776
X-LINKED SIDEROBLASTIC ANEMIA	0.0035461	0.13303602034380776
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.0035461	0.13303602034380776
SATOYOSHI SYNDROME	0.0035461	0.13303602034380776
HEMOCHROMATOSIS, TYPE 3; HFE3	0.0035461	0.13303602034380776
RHEUMATIC FEVER	0.0035461	0.13303602034380776
KAPOSI SARCOMA	0.0035461	0.13303602034380776
CHOLANGIOCARCINOMA	0.0035461	0.13303602034380776
FAMILIAL COLD URTICARIA	0.0035461	0.13303602034380776
MAST CELL SARCOMA	0.0035461	0.13303602034380776
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.0035461	0.13303602034380776
TOXIC EPIDERMAL NECROLYSIS	0.0035461	0.13303602034380776
TUBERCULOSIS	0.0035461	0.13303602034380776
MYXEDEMA	0.0035461	0.13303602034380776
HEMOCHROMATOSIS, TYPE 4; HFE4	0.0035461	0.13303602034380776
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.0035461	0.13303602034380776
CYCLIC NEUTROPENIA	0.0035461	0.13303602034380776
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.0035461	0.13303602034380776
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.0035461	0.13303602034380776
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.0035461	0.13303602034380776
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.0035461	0.13303602034380776
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.0035461	0.13303602034380776
KIKUCHI-FUJIMOTO DISEASE	0.0035461	0.13303602034380776
LEISHMANIASIS	0.0035461	0.13303602034380776
THYMIC EPITHELIAL NEOPLASM	0.0035461	0.13303602034380776
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.0035461	0.13303602034380776
POLYMYOSITIS	0.0035461	0.13303602034380776
SCHNITZLER SYNDROME	0.0035461	0.13303602034380776
GASTROINTESTINAL STROMAL TUMOR	0.0035461	0.13303602034380776
FOLLICULAR LYMPHOMA	0.0035461	0.13303602034380776
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.0035461	0.13303602034380776
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0035461	0.13303602034380776
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.0035461	0.13303602034380776
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.0035461	0.13303602034380776
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	0.0035461	0.13303602034380776
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.0035461	0.13303602034380776
ACUTE MONOBLASTIC LEUKEMIA	0.0035461	0.13303602034380776
POSTPOLIOMYELITIS SYNDROME	0.0035461	0.13303602034380776
BARTH SYNDROME; BTHS	0.0035461	0.13303602034380776
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.0035461	0.13303602034380776
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00342466	0.12848005905942433
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00342466	0.12848005905942433
HYPERALDOSTERONISM, FAMILIAL, TYPE II; HALD2	0.00342466	0.12848005905942433
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00342466	0.12848005905942433
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.00342466	0.12848005905942433
PARAGANGLIOMAS 6	0.00342466	0.12848005905942433
APERT SYNDROME	0.00342466	0.12848005905942433
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00342466	0.12848005905942433
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.00342466	0.12848005905942433
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00342466	0.12848005905942433
FAMILIAL HYPERALDOSTERONISM TYPE III	0.00342466	0.12848005905942433
ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2	0.00342466	0.12848005905942433
ABDOMINAL OBESITY-METABOLIC SYNDROME 1	0.00342466	0.12848005905942433
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.00342466	0.12848005905942433
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.00342466	0.12848005905942433
POSTERIOR URETHRAL VALVE	0.00342466	0.12848005905942433
CATECHOLAMINE-PRODUCING TUMOR	0.00342466	0.12848005905942433
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.00342466	0.12848005905942433
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.00342466	0.12848005905942433
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.00342466	0.12848005905942433
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.00342466	0.12848005905942433
APPARENT MINERALOCORTICOID EXCESS	0.00342466	0.12848005905942433
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.00342466	0.12848005905942433
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.00342466	0.12848005905942433
FRASIER SYNDROME	0.00342466	0.12848005905942433
MONOSOMY X	0.00342466	0.12848005905942433
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00342466	0.12848005905942433
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.00342466	0.12848005905942433
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.00342466	0.12848005905942433
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00342466	0.12848005905942433
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00342466	0.12848005905942433
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00342466	0.12848005905942433
TRIMETHYLAMINURIA	0.00342466	0.12848005905942433
DENYS-DRASH SYNDROME	0.00342466	0.12848005905942433
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.00342466	0.12848005905942433
CAUDAL REGRESSION SEQUENCE	0.00342466	0.12848005905942433
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.00342466	0.12848005905942433
NEPHROBLASTOMA	0.00342466	0.12848005905942433
MARSHALL-SMITH SYNDROME; MRSHSS	0.00342466	0.12848005905942433
LCAT DEFICIENCY	0.00342466	0.12848005905942433
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.00342466	0.12848005905942433
POLYCYSTIC KIDNEY DISEASE 2	0.00342466	0.12848005905942433
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00342466	0.12848005905942433
MOSAIC MONOSOMY X	0.00342466	0.12848005905942433
WERNER SYNDROME	0.00342466	0.12848005905942433
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.00342466	0.12848005905942433
ALKAPTONURIA	0.00342466	0.12848005905942433
TURNER SYNDROME	0.00342466	0.12848005905942433
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.00342466	0.12848005905942433
CONGENITAL HYPOTHYROIDISM	0.00342466	0.12848005905942433
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00342466	0.12848005905942433
CIRRHOSIS, FAMILIAL	0.00342466	0.12848005905942433
LONG QT SYNDROME 13; LQT13	0.00342466	0.12848005905942433
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2	0.00342466	0.12848005905942433
SICKLE CELL ANEMIA	0.00342466	0.12848005905942433
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.00342466	0.12848005905942433
PSEUDOHYPOALDOSTERONISM, TYPE II	0.00342466	0.12848005905942433
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.00342466	0.12848005905942433
SECONDARY POLYCYTHEMIA	0.00342466	0.12848005905942433
RHABDOID TUMOR	0.00342466	0.12848005905942433
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00342466	0.12848005905942433
FAMILIAL PSEUDOHYPERKALEMIA	0.00342466	0.12848005905942433
PRIMARY LIPODYSTROPHY	0.00342466	0.12848005905942433
AMYLOIDOSIS, FAMILIAL VISCERAL	0.00342466	0.12848005905942433
TETANUS	0.00342466	0.12848005905942433
LIDDLE SYNDROME 2; LIDLS2	0.00342466	0.12848005905942433
LIDDLE SYNDROME 3; LIDLS3	0.00342466	0.12848005905942433
NAIL-PATELLA-LIKE RENAL DISEASE	0.00342466	0.12848005905942433
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00342466	0.12848005905942433
NELSON SYNDROME	0.00342466	0.12848005905942433
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00342466	0.12848005905942433
NEPHRONOPHTHISIS 1	0.00342466	0.12848005905942433
STIFF-PERSON SYNDROME; SPS	0.00342466	0.12848005905942433
ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3	0.00342466	0.12848005905942433
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.00342466	0.12848005905942433
CARDIOMYOPATHY-CATARACT-HIP SPINE DISEASE SYNDROME	0.00342466	0.12848005905942433
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 3	0.00342466	0.12848005905942433
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.00342466	0.12848005905942433
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.00342466	0.12848005905942433
MOYAMOYA DISEASE WITH EARLY-ONSET ACHALASIA	0.00342466	0.12848005905942433
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.00342466	0.12848005905942433
INTRACRANIAL HYPERTENSION, IDIOPATHIC	0.00342466	0.12848005905942433
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00342466	0.12848005905942433
FAMILIAL BICUSPID AORTIC VALVE	0.00342466	0.12848005905942433
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00342466	0.12848005905942433
PSEUDOXANTHOMA ELASTICUM	0.00342466	0.12848005905942433
PSEUDOHYPOALDOSTERONISM TYPE 2	0.00342466	0.12848005905942433
%613944 IGA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.00342466	0.12848005905942433
AORTA COARCTATION	0.00342466	0.12848005905942433
ALAGILLE SYNDROME	0.00342466	0.12848005905942433
MELORHEOSTOSIS WITH OSTEOPOIKILOSIS	0.00342466	0.12848005905942433
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.00342466	0.12848005905942433
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.00342466	0.12848005905942433
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.00342466	0.12848005905942433
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00342466	0.12848005905942433
ALAGILLE SYNDROME 2	0.00342466	0.12848005905942433
CONGENITAL PULMONARY VEINS ATRESIA OR STENOSIS	0.00342466	0.12848005905942433
FAMILIAL PARTIAL LIPODYSTROPHY, KÖBBERLING TYPE	0.00342466	0.12848005905942433
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.00342466	0.12848005905942433
ACQUIRED GENERALIZED LIPODYSTROPHY	0.00342466	0.12848005905942433
GRANGE SYNDROME	0.00342466	0.12848005905942433
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.00342466	0.12848005905942433
NAIL-PATELLA SYNDROME	0.00342466	0.12848005905942433
POLYARTERITIS NODOSA	0.00342466	0.12848005905942433
%161900 RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1;;NEPHROPATHY, FAMILIAL;;NEPHRITIS, FAMILIAL, WITHOUT DEAFNESS OR OCULAR DEFECT;;RENAL FAILURE, ADULT-ONSET; AORF	0.00342466	0.12848005905942433
POLYCYSTIC KIDNEYS	0.00342466	0.12848005905942433
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00342466	0.12848005905942433
MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	0.00342466	0.12848005905942433
OCHOA SYNDROME	0.00342466	0.12848005905942433
LIDDLE SYNDROME 1; LIDLS1	0.00342466	0.12848005905942433
PRIMARY PROGRESSIVE FREEZING GAIT	0.00342466	0.12848005905942433
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00342466	0.12848005905942433
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00342466	0.12848005905942433
RENAL AGENESIS	0.00342466	0.12848005905942433
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	0.00342466	0.12848005905942433
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.00342466	0.12848005905942433
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.00342466	0.12848005905942433
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.00342466	0.12848005905942433
CYSTIC HAMARTOMA OF LUNG AND KIDNEY	0.00342466	0.12848005905942433
FIBRONECTIN GLOMERULOPATHY	0.00342466	0.12848005905942433
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.00342466	0.12848005905942433
HYPERALDOSTERONISM, FAMILIAL, TYPE IV	0.00342466	0.12848005905942433
CONGENITAL ADRENAL HYPERPLASIA	0.00342466	0.12848005905942433
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.00342466	0.12848005905942433
PLIN1-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00342466	0.12848005905942433
GLYCOGEN STORAGE DISEASE IB	0.00342466	0.12848005905942433
GLYCOGEN STORAGE DISEASE IA	0.00342466	0.12848005905942433
GAUCHER DISEASE, TYPE I	0.00342466	0.12848005905942433
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.00342466	0.12848005905942433
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.00342466	0.12848005905942433
POPOV-CHANG SYNDROME; POPCHAS	0.00342466	0.12848005905942433
PRIMARY MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS	0.00342466	0.12848005905942433
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.00342466	0.12848005905942433
JUVENILE PAGET DISEASE	0.00342466	0.12848005905942433
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00342466	0.12848005905942433
SENIOR-LOKEN SYNDROME	0.00342466	0.12848005905942433
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00342466	0.12848005905942433
PREECLAMPSIA	0.00342466	0.12848005905942433
X-LINKED HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00342466	0.12848005905942433
GANGLIONEUROMA	0.00342466	0.12848005905942433
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00342466	0.12848005905942433
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.00342466	0.12848005905942433
ADRENOCORTICAL CARCINOMA	0.00342466	0.12848005905942433
INFANT BOTULISM	0.00342466	0.12848005905942433
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00342466	0.12848005905942433
FAMILIAL HYPERALDOSTERONISM TYPE I	0.00342466	0.12848005905942433
STIFF SKIN SYNDROME	0.00342466	0.12848005905942433
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00342466	0.12848005905942433
POLYCYSTIC KIDNEY DISEASE 3	0.00342466	0.12848005905942433
SCALP-EAR-NIPPLE SYNDROME	0.00342466	0.12848005905942433
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.002502669	0.09389050618928317
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.002502669	0.09389050618928317
NORRIE DISEASE	0.002502669	0.09389050618928317
COHEN SYNDROME	0.002502669	0.09389050618928317
PELIZAEUS-MERZBACHER DISEASE	0.002502669	0.09389050618928317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.002502669	0.09389050618928317
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.002502669	0.09389050618928317
COFFIN-SIRIS SYNDROME 1; CSS1	0.002502669	0.09389050618928317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.002502669	0.09389050618928317
CORNELIA DE LANGE SYNDROME	0.002502669	0.09389050618928317
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.002502669	0.09389050618928317
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.002502669	0.09389050618928317
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.002502669	0.09389050618928317
CHROMOSOME 18Q DELETION SYNDROME	0.002502669	0.09389050618928317
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.002502669	0.09389050618928317
WITTEVEEN-KOLK SYNDROME	0.002502669	0.09389050618928317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.002502669	0.09389050618928317
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.002502669	0.09389050618928317
CHROMOSOME 19P13.13 DELETION SYNDROME	0.002502669	0.09389050618928317
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.002502669	0.09389050618928317
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.002502669	0.09389050618928317
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.002502669	0.09389050618928317
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.002502669	0.09389050618928317
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.002502669	0.09389050618928317
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.002502669	0.09389050618928317
COFFIN-SIRIS SYNDROME	0.002502669	0.09389050618928317
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.002502669	0.09389050618928317
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.002502669	0.09389050618928317
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.002502669	0.09389050618928317
MONOSOMY 9P	0.002502669	0.09389050618928317
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.002502669	0.09389050618928317
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.002502669	0.09389050618928317
8P11.2 DELETION SYNDROME	0.002502669	0.09389050618928317
TYROSINEMIA TYPE 2	0.002502669	0.09389050618928317
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.002502669	0.09389050618928317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.002502669	0.09389050618928317
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.002502669	0.09389050618928317
CONGENITAL TOXOPLASMOSIS	0.002502669	0.09389050618928317
20Q11.2 MICRODUPLICATION SYNDROME	0.002502669	0.09389050618928317
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.002502669	0.09389050618928317
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.002502669	0.09389050618928317
MEHMO SYNDROME	0.002502669	0.09389050618928317
ADENYLOSUCCINASE DEFICIENCY	0.002502669	0.09389050618928317
PETERS-PLUS SYNDROME; PTRPLS	0.002502669	0.09389050618928317
SMITH-LEMLI-OPITZ SYNDROME	0.002502669	0.09389050618928317
WOLF-HIRSCHHORN SYNDROME	0.002502669	0.09389050618928317
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.002502669	0.09389050618928317
CONGENITAL RUBELLA SYNDROME	0.002502669	0.09389050618928317
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.002502669	0.09389050618928317
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.002502669	0.09389050618928317
KABUKI SYNDROME	0.002502669	0.09389050618928317
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.002502669	0.09389050618928317
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.002502669	0.09389050618928317
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.002502669	0.09389050618928317
PRIMARY CUTIS VERTICIS GYRATA	0.002502669	0.09389050618928317
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.002502669	0.09389050618928317
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.002502669	0.09389050618928317
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.002502669	0.09389050618928317
HSD10 DISEASE	0.002502669	0.09389050618928317
DUBOWITZ SYNDROME	0.002502669	0.09389050618928317
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.002502669	0.09389050618928317
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.002502669	0.09389050618928317
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.002502669	0.09389050618928317
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.002502669	0.09389050618928317
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.002502669	0.09389050618928317
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.002502669	0.09389050618928317
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.002502669	0.09389050618928317
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.002502669	0.09389050618928317
PELIZAEUS-MERZBACHER DISEASE	0.002502669	0.09389050618928317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.002502669	0.09389050618928317
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.00196125	0.07357854964589068
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.00196125	0.07357854964589068
LOWRY-WOOD SYNDROME	0.00196125	0.07357854964589068
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00196125	0.07357854964589068
MIETENS SYNDROME	0.00196125	0.07357854964589068
ATAXIA-PANCYTOPENIA SYNDROME	0.00196125	0.07357854964589068
ERMINE PHENOTYPE	0.00196125	0.07357854964589068
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00196125	0.07357854964589068
ISOLATED COMPLEX I DEFICIENCY	0.00196125	0.07357854964589068
CHARGE SYNDROME	0.00196125	0.07357854964589068
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00196125	0.07357854964589068
MENTAL RETARDATION, X-LINKED 106; MRX106	0.00196125	0.07357854964589068
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00196125	0.07357854964589068
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.00196125	0.07357854964589068
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.00196125	0.07357854964589068
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00196125	0.07357854964589068
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00196125	0.07357854964589068
FANCONI ANEMIA	0.00196125	0.07357854964589068
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.00196125	0.07357854964589068
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.00196125	0.07357854964589068
MEVALONIC ACIDURIA; MEVA	0.00196125	0.07357854964589068
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00196125	0.07357854964589068
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00196125	0.07357854964589068
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00196125	0.07357854964589068
MUCOLIPIDOSIS TYPE IV	0.00196125	0.07357854964589068
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.00196125	0.07357854964589068
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00196125	0.07357854964589068
PETERS PLUS SYNDROME	0.00196125	0.07357854964589068
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.00196125	0.07357854964589068
MARINESCO-SJÖGREN SYNDROME	0.00196125	0.07357854964589068
6Q16 MICRODELETION SYNDROME	0.00196125	0.07357854964589068
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00196125	0.07357854964589068
FOCAL DERMAL HYPOPLASIA; FDH	0.00196125	0.07357854964589068
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.00196125	0.07357854964589068
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.00196125	0.07357854964589068
WAGR SYNDROME	0.00196125	0.07357854964589068
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00196125	0.07357854964589068
AICARDI-GOUTIERES SYNDROME 6	0.00196125	0.07357854964589068
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.001746239	0.06551216466798751
ATAXIA-TELANGIECTASIA	0.001746239	0.06551216466798751
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.001746239	0.06551216466798751
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.001746239	0.06551216466798751
CHÉDIAK-HIGASHI SYNDROME	0.001746239	0.06551216466798751
WOLFRAM SYNDROME	0.001746239	0.06551216466798751
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.001746239	0.06551216466798751
OCULOCEREBROCUTANEOUS SYNDROME	0.001746239	0.06551216466798751
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001746239	0.06551216466798751
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.001746239	0.06551216466798751
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.001746239	0.06551216466798751
OCULOCEREBROCUTANEOUS SYNDROME	0.001746239	0.06551216466798751
48,XXYY SYNDROME	0.001746239	0.06551216466798751
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.001746239	0.06551216466798751
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001746239	0.06551216466798751
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001746239	0.06551216466798751
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.001746239	0.06551216466798751
EPISODIC ATAXIA, TYPE 6	0.001746239	0.06551216466798751
SPINOCEREBELLAR ATAXIA TYPE 13	0.001746239	0.06551216466798751
INFANTILE NEUROAXONAL DYSTROPHY	0.001746239	0.06551216466798751
KNOBLOCH SYNDROME	0.001746239	0.06551216466798751
OCULOECTODERMAL SYNDROME; OES	0.001746239	0.06551216466798751
SCHINDLER DISEASE, TYPE I	0.001746239	0.06551216466798751
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.001746239	0.06551216466798751
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.001746239	0.06551216466798751
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.001746239	0.06551216466798751
SRD5A3-CDG	0.001746239	0.06551216466798751
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001746239	0.06551216466798751
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001746239	0.06551216466798751
SECONDARY SYRINGOMYELIA	0.001746239	0.06551216466798751
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.001746239	0.06551216466798751
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.001746239	0.06551216466798751
JOUBERT SYNDROME	0.001746239	0.06551216466798751
HUNTINGTON DISEASE-LIKE 1	0.001746239	0.06551216466798751
KALLMANN SYNDROME	0.001746239	0.06551216466798751
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001746239	0.06551216466798751
MALAN OVERGROWTH SYNDROME	0.001746239	0.06551216466798751
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001746239	0.06551216466798751
19P13.13 MICRODELETION SYNDROME	0.001746239	0.06551216466798751
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.001746239	0.06551216466798751
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.001746239	0.06551216466798751
NEONATAL ADRENOLEUKODYSTROPHY	0.001746239	0.06551216466798751
VICI SYNDROME	0.001746239	0.06551216466798751
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.001746239	0.06551216466798751
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.001746239	0.06551216466798751
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001746239	0.06551216466798751
SALLA DISEASE	0.001746239	0.06551216466798751
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001746239	0.06551216466798751
ANGELMAN SYNDROME	0.001746239	0.06551216466798751
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.001746239	0.06551216466798751
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.001746239	0.06551216466798751
GRISCELLI SYNDROME	0.001746239	0.06551216466798751
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001746239	0.06551216466798751
SIALIDOSIS TYPE 1	0.001746239	0.06551216466798751
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001746239	0.06551216466798751
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.001746239	0.06551216466798751
ELEJALDE DISEASE	0.001746239	0.06551216466798751
NARP SYNDROME	0.001746239	0.06551216466798751
ALSTRÖM SYNDROME	0.001746239	0.06551216466798751
LISSENCEPHALY, X-LINKED, 1; LISX1	0.001746239	0.06551216466798751
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.001746239	0.06551216466798751
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.001746239	0.06551216466798751
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.001746239	0.06551216466798751
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001746239	0.06551216466798751
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001746239	0.06551216466798751
6Q TERMINAL DELETION SYNDROME	0.001746239	0.06551216466798751
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.001746239	0.06551216466798751
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001746239	0.06551216466798751
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.001746239	0.06551216466798751
JOUBERT SYNDROME WITH RENAL DEFECT	0.001746239	0.06551216466798751
JOUBERT SYNDROME WITH OCULAR DEFECT	0.001746239	0.06551216466798751
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.001746239	0.06551216466798751
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.001746239	0.06551216466798751
NEURAMINIDASE DEFICIENCY	0.001746239	0.06551216466798751
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001746239	0.06551216466798751
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.001746239	0.06551216466798751
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001746239	0.06551216466798751
OROFACIODIGITAL SYNDROME TYPE 6	0.001746239	0.06551216466798751
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001746239	0.06551216466798751
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.001746239	0.06551216466798751
LEBER CONGENITAL AMAUROSIS	0.001746239	0.06551216466798751
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.001746239	0.06551216466798751
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.001746239	0.06551216466798751
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.001746239	0.06551216466798751
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.001746239	0.06551216466798751
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.001746239	0.06551216466798751
INFANTILE SIALIC ACID STORAGE DISEASE	0.001746239	0.06551216466798751
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.001746239	0.06551216466798751
GAPO SYNDROME; GAPOS	0.001746239	0.06551216466798751
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.001746239	0.06551216466798751
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001746239	0.06551216466798751
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.001746239	0.06551216466798751
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.001746239	0.06551216466798751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001746239	0.06551216466798751
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.001746239	0.06551216466798751
MOMO SYNDROME	0.001746239	0.06551216466798751
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001746239	0.06551216466798751
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001746239	0.06551216466798751
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.001746239	0.06551216466798751
FREE SIALIC ACID STORAGE DISEASE	0.001746239	0.06551216466798751
PERRAULT SYNDROME 5; PRLTS5	0.001746239	0.06551216466798751
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001746239	0.06551216466798751
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.001746239	0.06551216466798751
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.001746239	0.06551216466798751
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.001746239	0.06551216466798751
GRISCELLI SYNDROME TYPE 1	0.001746239	0.06551216466798751
HARTNUP DISEASE	0.001746239	0.06551216466798751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.001746239	0.06551216466798751
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.001746239	0.06551216466798751
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.001746239	0.06551216466798751
MENTAL RETARDATION, X-LINKED 104; MRX104	0.001746239	0.06551216466798751
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.001746239	0.06551216466798751
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.001746239	0.06551216466798751
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.001746239	0.06551216466798751
EPISODIC ATAXIA TYPE 3	0.001746239	0.06551216466798751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001746239	0.06551216466798751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001746239	0.06551216466798751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001746239	0.06551216466798751
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.001746239	0.06551216466798751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.001746239	0.06551216466798751
METACHROMATIC LEUKODYSTROPHY	0.001746239	0.06551216466798751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001746239	0.06551216466798751
INFANTILE REFSUM DISEASE	0.001746239	0.06551216466798751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001746239	0.06551216466798751
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001746239	0.06551216466798751
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.001746239	0.06551216466798751
LEIGH SYNDROME	0.001746239	0.06551216466798751
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001746239	0.06551216466798751
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001746239	0.06551216466798751
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001746239	0.06551216466798751
ACROCALLOSAL SYNDROME; ACLS	0.001746239	0.06551216466798751
OCULOCEREBRORENAL SYNDROME OF LOWE	0.001746239	0.06551216466798751
KRABBE DISEASE	0.001746239	0.06551216466798751
PONTINE TEGMENTAL CAP DYSPLASIA	0.001746239	0.06551216466798751
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001746239	0.06551216466798751
ALG2-CDG	0.001746239	0.06551216466798751
16Q24.3 MICRODELETION SYNDROME	0.001746239	0.06551216466798751
LEIGH SYNDROME; LS	0.001746239	0.06551216466798751
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001746239	0.06551216466798751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.001746239	0.06551216466798751
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.001746239	0.06551216466798751
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001746239	0.06551216466798751
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.001746239	0.06551216466798751
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001746239	0.06551216466798751
OPTIC PATHWAY GLIOMA	0.001746239	0.06551216466798751
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.001297849	0.04869029806468812
ALG1-CDG	0.001297849	0.04869029806468812
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.001297849	0.04869029806468812
ALG11-CDG	0.001297849	0.04869029806468812
MICROFORM HOLOPROSENCEPHALY	0.001297849	0.04869029806468812
ALG3-CDG	0.001297849	0.04869029806468812
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001297849	0.04869029806468812
TEMPLE-BARAITSER SYNDROME	0.001297849	0.04869029806468812
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.001297849	0.04869029806468812
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.001297849	0.04869029806468812
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001297849	0.04869029806468812
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001297849	0.04869029806468812
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001297849	0.04869029806468812
PHACE SYNDROME	0.001297849	0.04869029806468812
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.001297849	0.04869029806468812
RUBINSTEIN-TAYBI SYNDROME	0.001297849	0.04869029806468812
CK SYNDROME	0.001297849	0.04869029806468812
KLEEFSTRA SYNDROME	0.001297849	0.04869029806468812
14Q12 MICRODELETION SYNDROME	0.001297849	0.04869029806468812
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001297849	0.04869029806468812
SMITH-MAGENIS SYNDROME	0.001297849	0.04869029806468812
PYRUVATE DEHYDROGENASE DEFICIENCY	0.001297849	0.04869029806468812
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001297849	0.04869029806468812
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.001297849	0.04869029806468812
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.001297849	0.04869029806468812
DISTAL MONOSOMY 1Q	0.001297849	0.04869029806468812
RING CHROMOSOME 22 SYNDROME	0.001297849	0.04869029806468812
SJÖGREN-LARSSON SYNDROME	0.001297849	0.04869029806468812
STT3A-CDG	0.001297849	0.04869029806468812
CLASSIC PHENYLKETONURIA	0.001297849	0.04869029806468812
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.001297849	0.04869029806468812
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001297849	0.04869029806468812
MOYNAHAN SYNDROME	0.001297849	0.04869029806468812
ADNP SYNDROME	0.001297849	0.04869029806468812
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.001297849	0.04869029806468812
DPM1-CDG	0.001297849	0.04869029806468812
CAMOS SYNDROME	0.001297849	0.04869029806468812
SSR4-CDG	0.001297849	0.04869029806468812
DISTAL MONOSOMY 15Q	0.001297849	0.04869029806468812
10Q22.3Q23.3 MICRODELETION SYNDROME	0.001297849	0.04869029806468812
15Q14 MICRODELETION SYNDROME	0.001297849	0.04869029806468812
STT3B-CDG	0.001297849	0.04869029806468812
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001297849	0.04869029806468812
DPAGT1-CDG	0.001297849	0.04869029806468812
TETRASOMY 18P	0.001297849	0.04869029806468812
20P13 MICRODELETION SYNDROME	0.001297849	0.04869029806468812
FILIPPI SYNDROME	0.001297849	0.04869029806468812
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.001297849	0.04869029806468812
HALL-RIGGS SYNDROME	0.001297849	0.04869029806468812
RUVALCABA SYNDROME	0.001297849	0.04869029806468812
DUPLICATION/INVERSION 15Q11	0.001297849	0.04869029806468812
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001297849	0.04869029806468812
HARROD SYNDROME	0.001297849	0.04869029806468812
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001297849	0.04869029806468812
HOLOPROSENCEPHALY	0.001297849	0.04869029806468812
LATHOSTEROLOSIS	0.001297849	0.04869029806468812
22Q11.2 MICRODUPLICATION SYNDROME	0.001297849	0.04869029806468812
22Q11.2 DELETION SYNDROME	0.001297849	0.04869029806468812
MATERNAL PHENYLKETONURIA	0.001297849	0.04869029806468812
ADENYLOSUCCINATE LYASE DEFICIENCY	0.001297849	0.04869029806468812
MULTIPLE SULFATASE DEFICIENCY	0.001297849	0.04869029806468812
KOOLEN-DE VRIES SYNDROME	0.001297849	0.04869029806468812
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001297849	0.04869029806468812
3-HYDROXYISOBUTYRIC ACIDURIA	0.001297849	0.04869029806468812
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.001297849	0.04869029806468812
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.001297849	0.04869029806468812
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.001297849	0.04869029806468812
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.001297849	0.04869029806468812
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.001297849	0.04869029806468812
COFFIN-LOWRY SYNDROME	0.001297849	0.04869029806468812
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001297849	0.04869029806468812
9Q33.3Q34.11 MICRODELETION SYNDROME	0.001297849	0.04869029806468812
WIEDEMANN-STEINER SYNDROME	0.001297849	0.04869029806468812
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.001297849	0.04869029806468812
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.001297849	0.04869029806468812
RENPENNING SYNDROME	0.001297849	0.04869029806468812
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.001297849	0.04869029806468812
DISTAL MONOSOMY 10Q	0.001297849	0.04869029806468812
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.001297849	0.04869029806468812
RENIER-GABREELS-JASPER SYNDROME	0.001297849	0.04869029806468812
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.001297849	0.04869029806468812
HEREDITARY METHEMOGLOBINEMIA	0.001297849	0.04869029806468812
MONOSOMY 18Q	0.001297849	0.04869029806468812
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.001297849	0.04869029806468812
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.001297849	0.04869029806468812
LOWRY-MACLEAN SYNDROME	0.001297849	0.04869029806468812
GALACTOSEMIA	0.001297849	0.04869029806468812
WALKER-WARBURG SYNDROME	0.001297849	0.04869029806468812
MEVALONIC ACIDURIA	0.001297849	0.04869029806468812
PITT-HOPKINS SYNDROME	0.001297849	0.04869029806468812
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.001297849	0.04869029806468812
TRIPLE A SYNDROME	0.001297849	0.04869029806468812
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.001297849	0.04869029806468812
DISTAL MONOSOMY 7Q36	0.001297849	0.04869029806468812
1Q21.1 MICRODELETION SYNDROME	0.001297849	0.04869029806468812
MICRO SYNDROME	0.001297849	0.04869029806468812
DISTAL MONOSOMY 3P	0.001297849	0.04869029806468812
8P23.1 MICRODELETION SYNDROME	0.001297849	0.04869029806468812
ANGELMAN SYNDROME	0.001297849	0.04869029806468812
XP22.13P22.2 DUPLICATION SYNDROME	0.001297849	0.04869029806468812
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.001297849	0.04869029806468812
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001297849	0.04869029806468812
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001297849	0.04869029806468812
KBG SYNDROME	0.001297849	0.04869029806468812
2Q23.1 MICRODELETION SYNDROME	0.001297849	0.04869029806468812
NEVUS COMEDONICUS SYNDROME	0.001297849	0.04869029806468812
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.001297849	0.04869029806468812
5Q35 MICRODUPLICATION SYNDROME	0.001297849	0.04869029806468812
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001297849	0.04869029806468812
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.001297849	0.04869029806468812
LEUKOCYTE ADHESION DEFICIENCY	0.001297849	0.04869029806468812
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.001297849	0.04869029806468812
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.001297849	0.04869029806468812
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.001297849	0.04869029806468812
CEDNIK SYNDROME	0.001297849	0.04869029806468812
WOLCOTT-RALLISON SYNDROME	0.001297849	0.04869029806468812
WORSTER-DROUGHT SYNDROME	0.001297849	0.04869029806468812
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.001297849	0.04869029806468812
SANJAD-SAKATI SYNDROME	0.001297849	0.04869029806468812
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001297849	0.04869029806468812
WOLF-HIRSCHHORN SYNDROME	0.001297849	0.04869029806468812
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.001297849	0.04869029806468812
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.001297849	0.04869029806468812
BARAITSER-WINTER SYNDROME 1; BRWS1	0.001297849	0.04869029806468812
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001297849	0.04869029806468812
EMANUEL SYNDROME	0.001297849	0.04869029806468812
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.001297849	0.04869029806468812
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001297849	0.04869029806468812
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.001297849	0.04869029806468812
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001297849	0.04869029806468812
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.001297849	0.04869029806468812
JABERI-ELAHI SYNDROME; JABELS	0.001297849	0.04869029806468812
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.001297849	0.04869029806468812
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.001297849	0.04869029806468812
CHROMOSOME 1P35 DELETION SYNDROME	0.001297849	0.04869029806468812
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001297849	0.04869029806468812
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001297849	0.04869029806468812
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001297849	0.04869029806468812
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.001297849	0.04869029806468812
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.001297849	0.04869029806468812
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.001297849	0.04869029806468812
KLEEFSTRA SYNDROME 2; KLEFS2	0.001297849	0.04869029806468812
CHROMOSOME 10Q26 DELETION SYNDROME	0.001297849	0.04869029806468812
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001297849	0.04869029806468812
KLEEFSTRA SYNDROME	0.001297849	0.04869029806468812
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001297849	0.04869029806468812
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.001297849	0.04869029806468812
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001297849	0.04869029806468812
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001297849	0.04869029806468812
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.001297849	0.04869029806468812
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001297849	0.04869029806468812
AL KAISSI SYNDROME; ALKAS	0.001297849	0.04869029806468812
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001297849	0.04869029806468812
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001297849	0.04869029806468812
AICARDI-GOUTIERES SYNDROME 7	0.001297849	0.04869029806468812
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001297849	0.04869029806468812
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.001297849	0.04869029806468812
SUPRABULBAR PARESIS, CONGENITAL	0.001297849	0.04869029806468812
COFFIN-SIRIS SYNDROME 3; CSS3	0.001297849	0.04869029806468812
FILIPPI SYNDROME; FLPIS	0.001297849	0.04869029806468812
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.001297849	0.04869029806468812
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.001297849	0.04869029806468812
XYLOSIDASE DEFICIENCY	0.001297849	0.04869029806468812
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001297849	0.04869029806468812
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001297849	0.04869029806468812
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.001297849	0.04869029806468812
MEHMO SYNDROME; MEHMO	0.001297849	0.04869029806468812
PIERPONT SYNDROME	0.001297849	0.04869029806468812
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001297849	0.04869029806468812
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.001297849	0.04869029806468812
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001297849	0.04869029806468812
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.001297849	0.04869029806468812
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001297849	0.04869029806468812
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.001297849	0.04869029806468812
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001297849	0.04869029806468812
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.001297849	0.04869029806468812
SECKEL SYNDROME 7; SCKL7	0.001297849	0.04869029806468812
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001297849	0.04869029806468812
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.001297849	0.04869029806468812
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.001297849	0.04869029806468812
KABUKI SYNDROME 1	0.001297849	0.04869029806468812
KBG SYNDROME	0.001297849	0.04869029806468812
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.001297849	0.04869029806468812
HOLOPROSENCEPHALY 2; HPE2	0.001297849	0.04869029806468812
LATHOSTEROLOSIS	0.001297849	0.04869029806468812
COFFIN-SIRIS SYNDROME 4; CSS4	0.001297849	0.04869029806468812
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001297849	0.04869029806468812
PHELAN-MCDERMID SYNDROME	0.001297849	0.04869029806468812
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001297849	0.04869029806468812
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001297849	0.04869029806468812
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.001297849	0.04869029806468812
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.001297849	0.04869029806468812
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001297849	0.04869029806468812
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001297849	0.04869029806468812
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.001297849	0.04869029806468812
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.001297849	0.04869029806468812
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001297849	0.04869029806468812
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001297849	0.04869029806468812
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001297849	0.04869029806468812
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001297849	0.04869029806468812
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.001297849	0.04869029806468812
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.001297849	0.04869029806468812
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001297849	0.04869029806468812
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001297849	0.04869029806468812
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.001297849	0.04869029806468812
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001297849	0.04869029806468812
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.001297849	0.04869029806468812
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001297849	0.04869029806468812
PERRAULT SYNDROME 3	0.001297849	0.04869029806468812
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001297849	0.04869029806468812
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.001297849	0.04869029806468812
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001297849	0.04869029806468812
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.001297849	0.04869029806468812
C SYNDROME	0.001297849	0.04869029806468812
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001297849	0.04869029806468812
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.001297849	0.04869029806468812
COFFIN-SIRIS SYNDROME 5	0.001297849	0.04869029806468812
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001297849	0.04869029806468812
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001297849	0.04869029806468812
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001297849	0.04869029806468812
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.001297849	0.04869029806468812
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001297849	0.04869029806468812
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001297849	0.04869029806468812
LISSENCEPHALY 4	0.001297849	0.04869029806468812
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.001297849	0.04869029806468812
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.001297849	0.04869029806468812
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.001297849	0.04869029806468812
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001297849	0.04869029806468812
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.001297849	0.04869029806468812
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001297849	0.04869029806468812
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001297849	0.04869029806468812
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001297849	0.04869029806468812
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001297849	0.04869029806468812
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001297849	0.04869029806468812
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001297849	0.04869029806468812
COHEN SYNDROME	0.001297849	0.04869029806468812
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.001297849	0.04869029806468812
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.001297849	0.04869029806468812
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001297849	0.04869029806468812
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001297849	0.04869029806468812
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001297849	0.04869029806468812
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.001297849	0.04869029806468812
LISSENCEPHALY 8; LIS8	0.001297849	0.04869029806468812
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.001297849	0.04869029806468812
LISSENCEPHALY 3; LIS3	0.001297849	0.04869029806468812
PITT-HOPKINS SYNDROME	0.001297849	0.04869029806468812
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001297849	0.04869029806468812
PSEUDO-TORCH SYNDROME 2	0.001297849	0.04869029806468812
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001297849	0.04869029806468812
POTOCKI-LUPSKI SYNDROME	0.001297849	0.04869029806468812
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001297849	0.04869029806468812
CHROMOSOME 16P13.3 DELETION SYNDROME	0.001297849	0.04869029806468812
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.001297849	0.04869029806468812
PHENYLKETONURIA	0.001297849	0.04869029806468812
KOOLEN-DE VRIES SYNDROME; KDVS	0.001297849	0.04869029806468812
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001297849	0.04869029806468812
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.001297849	0.04869029806468812
BANGSTAD SYNDROME	0.001297849	0.04869029806468812
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.001297849	0.04869029806468812
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.001297849	0.04869029806468812
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.001297849	0.04869029806468812
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.001297849	0.04869029806468812
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001297849	0.04869029806468812
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001297849	0.04869029806468812
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001297849	0.04869029806468812
ASPARTYLGLUCOSAMINURIA; AGU	0.001297849	0.04869029806468812
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001297849	0.04869029806468812
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.001297849	0.04869029806468812
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001297849	0.04869029806468812
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.001297849	0.04869029806468812
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.001297849	0.04869029806468812
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.001297849	0.04869029806468812
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001297849	0.04869029806468812
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001297849	0.04869029806468812
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001297849	0.04869029806468812
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001297849	0.04869029806468812
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.001297849	0.04869029806468812
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.001297849	0.04869029806468812
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001297849	0.04869029806468812
INCONTINENTIA PIGMENTI; IP	0.001297849	0.04869029806468812
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.001297849	0.04869029806468812
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.001297849	0.04869029806468812
INFANTILE LIVER FAILURE SYNDROME 1	0.001297849	0.04869029806468812
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.001297849	0.04869029806468812
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001297849	0.04869029806468812
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001297849	0.04869029806468812
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.001297849	0.04869029806468812
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.001297849	0.04869029806468812
CYCLIC VOMITING SYNDROME	0.001297849	0.04869029806468812
KEARNS-SAYRE SYNDROME; KSS	0.001297849	0.04869029806468812
2Q37 MICRODELETION SYNDROME	0.001297849	0.04869029806468812
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.001297849	0.04869029806468812
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001297849	0.04869029806468812
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001297849	0.04869029806468812
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.001297849	0.04869029806468812
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.001297849	0.04869029806468812
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.001297849	0.04869029806468812
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.001297849	0.04869029806468812
COFFIN-LOWRY SYNDROME; CLS	0.001297849	0.04869029806468812
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001297849	0.04869029806468812
ISOLATED CEREBELLAR AGENESIS	0.001297849	0.04869029806468812
MENTAL RETARDATION, X-LINKED 102	0.001297849	0.04869029806468812
17Q11.2 MICRODUPLICATION SYNDROME	0.001297849	0.04869029806468812
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001297849	0.04869029806468812
MOWAT-WILSON SYNDROME; MOWS	0.001297849	0.04869029806468812
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001297849	0.04869029806468812
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.001297849	0.04869029806468812
ANGELMAN SYNDROME (TYPE 1)	0.001297849	0.04869029806468812
XQ28 (MECP2) DUPLICATION	0.001297849	0.04869029806468812
ANGELMAN SYNDROME (TYPE 2)	0.001297849	0.04869029806468812
SYMMETRICAL THALAMIC CALCIFICATIONS	0.001297849	0.04869029806468812
C SYNDROME	0.001297849	0.04869029806468812
HOLOPROSENCEPHALY 1; HPE1	0.001297849	0.04869029806468812
BRANCHIOSKELETOGENITAL SYNDROME	0.001297849	0.04869029806468812
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001297849	0.04869029806468812
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001297849	0.04869029806468812
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001297849	0.04869029806468812
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.001297849	0.04869029806468812
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001297849	0.04869029806468812
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.001297849	0.04869029806468812
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.001297849	0.04869029806468812
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001297849	0.04869029806468812
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001297849	0.04869029806468812
ÅLAND ISLANDS EYE DISEASE	0.00120482	0.045200208124595034
GILLESPIE SYNDROME; GLSP	0.00120482	0.045200208124595034
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00120482	0.045200208124595034
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.00120482	0.045200208124595034
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00120482	0.045200208124595034
RICHARDS-RUNDLE SYNDROME; RRNS	0.00120482	0.045200208124595034
AMYOTROPHIC DYSTONIC PARAPLEGIA	0.00120482	0.045200208124595034
CONE-ROD DYSTROPHY 20; CORD20	0.00120482	0.045200208124595034
PETERS ANOMALY	0.00120482	0.045200208124595034
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00120482	0.045200208124595034
BALLER-GEROLD SYNDROME	0.00120482	0.045200208124595034
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00120482	0.045200208124595034
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.00120482	0.045200208124595034
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 38; SCA38	0.00120482	0.045200208124595034
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00120482	0.045200208124595034
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00120482	0.045200208124595034
ARIMA SYNDROME	0.00120482	0.045200208124595034
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.00120482	0.045200208124595034
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00120482	0.045200208124595034
BLUE CONE MONOCHROMACY; BCM	0.00120482	0.045200208124595034
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00120482	0.045200208124595034
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00120482	0.045200208124595034
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00120482	0.045200208124595034
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.00120482	0.045200208124595034
OSTEOPETROSIS AND RELATED DISORDERS	0.00120482	0.045200208124595034
CHIARI MALFORMATION TYPE II	0.00120482	0.045200208124595034
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00120482	0.045200208124595034
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.00120482	0.045200208124595034
MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES	0.00120482	0.045200208124595034
JOUBERT SYNDROME 27	0.00120482	0.045200208124595034
ENDOSTEAL HYPEROSTOSIS, WORTH TYPE	0.00120482	0.045200208124595034
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00120482	0.045200208124595034
JOUBERT SYNDROME 28	0.00120482	0.045200208124595034
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.00120482	0.045200208124595034
OCULOCUTANEOUS ALBINISM TYPE 4	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.00120482	0.045200208124595034
PAPILLARY TUMOR OF THE PINEAL REGION	0.00120482	0.045200208124595034
PINEOCYTOMA	0.00120482	0.045200208124595034
SPASMUS NUTANS	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00120482	0.045200208124595034
REFSUM DISEASE	0.00120482	0.045200208124595034
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00120482	0.045200208124595034
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 34; SCA34	0.00120482	0.045200208124595034
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00120482	0.045200208124595034
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00120482	0.045200208124595034
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.00120482	0.045200208124595034
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00120482	0.045200208124595034
LEBER CONGENITAL AMAUROSIS 12; LCA12	0.00120482	0.045200208124595034
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.00120482	0.045200208124595034
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00120482	0.045200208124595034
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00120482	0.045200208124595034
DYSOSTEOSCLEROSIS	0.00120482	0.045200208124595034
ANIRIDIA	0.00120482	0.045200208124595034
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00120482	0.045200208124595034
VITREORETINOCHOROIDOPATHY; VRCP	0.00120482	0.045200208124595034
LAURENCE-MOON SYNDROME	0.00120482	0.045200208124595034
SPONDYLO-OCULAR SYNDROME	0.00120482	0.045200208124595034
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00120482	0.045200208124595034
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00120482	0.045200208124595034
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00120482	0.045200208124595034
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00120482	0.045200208124595034
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.00120482	0.045200208124595034
CRANIOFRONTONASAL SYNDROME; CFNS	0.00120482	0.045200208124595034
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00120482	0.045200208124595034
ISOLATED ANIRIDIA	0.00120482	0.045200208124595034
BENIGN PAROXYSMAL TONIC UPGAZE OF CHILDHOOD WITH ATAXIA	0.00120482	0.045200208124595034
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00120482	0.045200208124595034
CATARACT 19, MULTIPLE TYPES; CTRCT19	0.00120482	0.045200208124595034
MORNING GLORY DISC ANOMALY	0.00120482	0.045200208124595034
MELKERSSON-ROSENTHAL SYNDROME	0.00120482	0.045200208124595034
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.00120482	0.045200208124595034
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.00120482	0.045200208124595034
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00120482	0.045200208124595034
JOUBERT SYNDROME 7	0.00120482	0.045200208124595034
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.00120482	0.045200208124595034
NAVAJO NEUROHEPATOPATHY	0.00120482	0.045200208124595034
MARSHALL SYNDROME	0.00120482	0.045200208124595034
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00120482	0.045200208124595034
PEROXISOME BIOGENESIS DISORDER 10B	0.00120482	0.045200208124595034
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.00120482	0.045200208124595034
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.00120482	0.045200208124595034
JALILI SYNDROME	0.00120482	0.045200208124595034
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00120482	0.045200208124595034
ACHROMATOPSIA 7; ACHM7	0.00120482	0.045200208124595034
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00120482	0.045200208124595034
YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME	0.00120482	0.045200208124595034
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00120482	0.045200208124595034
CENANI-LENZ SYNDROME	0.00120482	0.045200208124595034
CATARACT-MICROCORNEA SYNDROME	0.00120482	0.045200208124595034
DANDY-WALKER SYNDROME	0.00120482	0.045200208124595034
SENIOR-LOKEN SYNDROME 9	0.00120482	0.045200208124595034
CODAS SYNDROME	0.00120482	0.045200208124595034
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.00120482	0.045200208124595034
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00120482	0.045200208124595034
JOUBERT SYNDROME 24	0.00120482	0.045200208124595034
X-LINKED RETINAL DYSPLASIA	0.00120482	0.045200208124595034
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 21	0.00120482	0.045200208124595034
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.00120482	0.045200208124595034
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00120482	0.045200208124595034
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.00120482	0.045200208124595034
RETINITIS PIGMENTOSA 20	0.00120482	0.045200208124595034
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.00120482	0.045200208124595034
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00120482	0.045200208124595034
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00120482	0.045200208124595034
RICHARDS-RUNDLE SYNDROME	0.00120482	0.045200208124595034
PEROXISOME BIOGENESIS DISORDER 5B	0.00120482	0.045200208124595034
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.00120482	0.045200208124595034
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00120482	0.045200208124595034
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.00120482	0.045200208124595034
USHER SYNDROME	0.00120482	0.045200208124595034
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.00120482	0.045200208124595034
ARNOLD-CHIARI MALFORMATION TYPE I	0.00120482	0.045200208124595034
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.00120482	0.045200208124595034
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.00120482	0.045200208124595034
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00120482	0.045200208124595034
CRANIOECTODERMAL DYSPLASIA 1	0.00120482	0.045200208124595034
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.00120482	0.045200208124595034
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.00120482	0.045200208124595034
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.00120482	0.045200208124595034
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00120482	0.045200208124595034
X-LINKED RECESSIVE OCULAR ALBINISM	0.00120482	0.045200208124595034
245800 LAURENCE-MOON SYNDROME	0.00120482	0.045200208124595034
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.00120482	0.045200208124595034
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00120482	0.045200208124595034
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.00120482	0.045200208124595034
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.00120482	0.045200208124595034
OCULOCUTANEOUS ALBINISM	0.00120482	0.045200208124595034
EPISODIC ATAXIA, TYPE 8	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 18	0.00120482	0.045200208124595034
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.00120482	0.045200208124595034
OCULOCUTANEOUS ALBINISM TYPE 3	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00120482	0.045200208124595034
X-LINKED IMMUNONEUROLOGIC DISORDER	0.00120482	0.045200208124595034
CRANIOECTODERMAL DYSPLASIA	0.00120482	0.045200208124595034
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.00120482	0.045200208124595034
CRANIOFACIAL DYSSYNOSTOSIS	0.00120482	0.045200208124595034
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00120482	0.045200208124595034
CONE-ROD DYSTROPHY 6; CORD6	0.00120482	0.045200208124595034
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00120482	0.045200208124595034
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00120482	0.045200208124595034
CONE DYSTROPHY 4	0.00120482	0.045200208124595034
RETINITIS PIGMENTOSA	0.00120482	0.045200208124595034
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.00120482	0.045200208124595034
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00120482	0.045200208124595034
LEBER CONGENITAL AMAUROSIS 16	0.00120482	0.045200208124595034
CARDIOFACIOCUTANEOUS SYNDROME	0.00120482	0.045200208124595034
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00120482	0.045200208124595034
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00120482	0.045200208124595034
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.00120482	0.045200208124595034
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00120482	0.045200208124595034
JOUBERT SYNDROME 26	0.00120482	0.045200208124595034
CEREBELLAR HYPOPLASIA	0.00120482	0.045200208124595034
RENAL COLOBOMA SYNDROME	0.00120482	0.045200208124595034
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.00120482	0.045200208124595034
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.00120482	0.045200208124595034
OCULOCUTANEOUS ALBINISM TYPE 2	0.00120482	0.045200208124595034
OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY; ODRMD	0.00120482	0.045200208124595034
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.00120482	0.045200208124595034
NEPHRONOPHTHISIS 11; NPHP11	0.00120482	0.045200208124595034
FARBER DISEASE	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00120482	0.045200208124595034
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00120482	0.045200208124595034
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.00120482	0.045200208124595034
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00120482	0.045200208124595034
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 18	0.00120482	0.045200208124595034
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.00120482	0.045200208124595034
NYSTAGMUS, VOLUNTARY	0.00120482	0.045200208124595034
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.00120482	0.045200208124595034
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00120482	0.045200208124595034
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00120482	0.045200208124595034
EPISODIC ATAXIA TYPE 7	0.00120482	0.045200208124595034
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 2	0.00120482	0.045200208124595034
GORLIN-CHAUDHRY-MOSS SYNDROME	0.00120482	0.045200208124595034
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00120482	0.045200208124595034
COLOBOMA, OCULAR	0.00120482	0.045200208124595034
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00120482	0.045200208124595034
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00120482	0.045200208124595034
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 29	0.00120482	0.045200208124595034
TERATOMA, PINEAL	0.00120482	0.045200208124595034
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.00120482	0.045200208124595034
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00120482	0.045200208124595034
ATAXIA WITH VITAMIN E DEFICIENCY	0.00120482	0.045200208124595034
ACRO-RENAL-OCULAR SYNDROME	0.00120482	0.045200208124595034
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 60	0.00120482	0.045200208124595034
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00120482	0.045200208124595034
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 20	0.00120482	0.045200208124595034
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 31	0.00120482	0.045200208124595034
PETERS ANOMALY	0.00120482	0.045200208124595034
OCULOCUTANEOUS ALBINISM TYPE 5	0.00120482	0.045200208124595034
JOUBERT SYNDROME 3; JBTS3	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00120482	0.045200208124595034
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.00120482	0.045200208124595034
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.00120482	0.045200208124595034
SPASTIC PARAPLEGIA TYPE 7	0.00120482	0.045200208124595034
SCLEROSTEOSIS 1; SOST1	0.00120482	0.045200208124595034
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00120482	0.045200208124595034
OPHTHALMOPLEGIA, FAMILIAL STATIC	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 1	0.00120482	0.045200208124595034
JOUBERT SYNDROME 2	0.00120482	0.045200208124595034
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00120482	0.045200208124595034
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00120482	0.045200208124595034
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00120482	0.045200208124595034
GAPO SYNDROME	0.00120482	0.045200208124595034
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 14	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 13	0.00120482	0.045200208124595034
FAMILIAL PAROXYSMAL ATAXIA	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 1	0.00120482	0.045200208124595034
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.00120482	0.045200208124595034
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00120482	0.045200208124595034
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.00120482	0.045200208124595034
CONE-ROD DYSTROPHY, X-LINKED, 3	0.00120482	0.045200208124595034
BAKER-GORDON SYNDROME; BAGOS	0.00120482	0.045200208124595034
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00120482	0.045200208124595034
DISTAL TRISOMY 6P	0.00120482	0.045200208124595034
X-LINKED ENDOTHELIAL CORNEAL DYSTROPHY	0.00120482	0.045200208124595034
NOONAN SYNDROME	0.00120482	0.045200208124595034
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00120482	0.045200208124595034
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.00120482	0.045200208124595034
SOTOS SYNDROME 2	0.00120482	0.045200208124595034
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00120482	0.045200208124595034
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.00120482	0.045200208124595034
WAARDENBURG-SHAH SYNDROME	0.00120482	0.045200208124595034
PEROXISOME BIOGENESIS DISORDER 6B	0.00120482	0.045200208124595034
LENTIGINES	0.00120482	0.045200208124595034
SPONDYLOOCULAR SYNDROME; SOS	0.00120482	0.045200208124595034
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00120482	0.045200208124595034
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.00120482	0.045200208124595034
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.00120482	0.045200208124595034
RETINITIS PIGMENTOSA 12; RP12	0.00120482	0.045200208124595034
SENIOR-LOKEN SYNDROME 3	0.00120482	0.045200208124595034
RETINITIS PIGMENTOSA 14	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 38	0.00120482	0.045200208124595034
OLIVER-MCFARLANE SYNDROME	0.00120482	0.045200208124595034
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00120482	0.045200208124595034
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00120482	0.045200208124595034
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.00120482	0.045200208124595034
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.00120482	0.045200208124595034
LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	0.00120482	0.045200208124595034
CHANARIN-DORFMAN SYNDROME	0.00120482	0.045200208124595034
OROFACIODIGITAL SYNDROME VI	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00120482	0.045200208124595034
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.00120482	0.045200208124595034
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00120482	0.045200208124595034
REFSUM DISEASE	0.00120482	0.045200208124595034
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00120482	0.045200208124595034
SYRINGOMYELIA, ISOLATED	0.00120482	0.045200208124595034
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 26	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 25	0.00120482	0.045200208124595034
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.00120482	0.045200208124595034
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00120482	0.045200208124595034
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00120482	0.045200208124595034
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00120482	0.045200208124595034
NYSTAGMUS, MYOCLONIC	0.00120482	0.045200208124595034
JOUBERT SYNDROME 32; JBTS32	0.00120482	0.045200208124595034
JOUBERT SYNDROME 31; JBTS31	0.00120482	0.045200208124595034
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 28	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 45; SCA45	0.00120482	0.045200208124595034
JOUBERT SYNDROME 4	0.00120482	0.045200208124595034
%615312 ALBINISM, OCULOCUTANEOUS, TYPE V; OCA5	0.00120482	0.045200208124595034
ANTERIOR SEGMENT DYSGENESIS 2; ASGD2	0.00120482	0.045200208124595034
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00120482	0.045200208124595034
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00120482	0.045200208124595034
USHER SYNDROME TYPE 2	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.00120482	0.045200208124595034
JOUBERT SYNDROME 5	0.00120482	0.045200208124595034
FETAL IODINE SYNDROME	0.00120482	0.045200208124595034
TREMOR, NYSTAGMUS, AND DUODENAL ULCER	0.00120482	0.045200208124595034
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00120482	0.045200208124595034
ALAND ISLAND EYE DISEASE	0.00120482	0.045200208124595034
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00120482	0.045200208124595034
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.00120482	0.045200208124595034
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.00120482	0.045200208124595034
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.00120482	0.045200208124595034
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00120482	0.045200208124595034
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00120482	0.045200208124595034
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00120482	0.045200208124595034
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 26	0.00120482	0.045200208124595034
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00120482	0.045200208124595034
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.00120482	0.045200208124595034
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.00120482	0.045200208124595034
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 7	0.00120482	0.045200208124595034
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 3	0.00120482	0.045200208124595034
FRIEDREICH ATAXIA	0.00120482	0.045200208124595034
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.00120482	0.045200208124595034
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00120482	0.045200208124595034
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00120482	0.045200208124595034
REVESZ SYNDROME	0.00120482	0.045200208124595034
SPASTIC PARAPLEGIA TYPE 2	0.00120482	0.045200208124595034
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 59	0.00120482	0.045200208124595034
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 8	0.00120482	0.045200208124595034
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.00120482	0.045200208124595034
EXUDATIVE VITREORETINOPATHY 7; EVR7	0.00120482	0.045200208124595034
CHIARI MALFORMATION TYPE I	0.00120482	0.045200208124595034
DIENCEPHALIC SYNDROME	0.00120482	0.045200208124595034
CEREBELLAR ATAXIA, CAYMAN TYPE	0.00120482	0.045200208124595034
NANCE-HORAN SYNDROME	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 46; SCA46	0.00120482	0.045200208124595034
FOVEAL HYPOPLASIA 2; FVH2	0.00120482	0.045200208124595034
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00120482	0.045200208124595034
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00120482	0.045200208124595034
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.00120482	0.045200208124595034
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.00120482	0.045200208124595034
OCULOCUTANEOUS ALBINISM TYPE 6	0.00120482	0.045200208124595034
BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA	0.00120482	0.045200208124595034
OCULAR ALBINISM	0.00120482	0.045200208124595034
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.00075643	0.028378341521295647
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00075643	0.028378341521295647
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.00075643	0.028378341521295647
RHIZOMELIC SYNDROME, URBACH TYPE	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
RENAL TUBULAR DYSGENESIS	0.00075643	0.028378341521295647
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00075643	0.028378341521295647
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.00075643	0.028378341521295647
ALAZAMI SYNDROME; ALAZS	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00075643	0.028378341521295647
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00075643	0.028378341521295647
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00075643	0.028378341521295647
STIMMLER SYNDROME	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY 11	0.00075643	0.028378341521295647
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.00075643	0.028378341521295647
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00075643	0.028378341521295647
STROMME SYNDROME; STROMS	0.00075643	0.028378341521295647
ADAMS-OLIVER SYNDROME 3; AOS3	0.00075643	0.028378341521295647
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00075643	0.028378341521295647
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00075643	0.028378341521295647
ERYTHROKERATODERMIA VARIABILIS	0.00075643	0.028378341521295647
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00075643	0.028378341521295647
FEINGOLD SYNDROME 2; FGLDS2	0.00075643	0.028378341521295647
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00075643	0.028378341521295647
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00075643	0.028378341521295647
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.00075643	0.028378341521295647
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00075643	0.028378341521295647
JOHANSON-BLIZZARD SYNDROME; JBS	0.00075643	0.028378341521295647
SECKEL SYNDROME	0.00075643	0.028378341521295647
SATOYOSHI SYNDROME	0.00075643	0.028378341521295647
DISTAL 17P13.1 MICRODELETION SYNDROME	0.00075643	0.028378341521295647
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00075643	0.028378341521295647
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00075643	0.028378341521295647
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00075643	0.028378341521295647
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00075643	0.028378341521295647
MENTAL RETARDATION, X-LINKED 63	0.00075643	0.028378341521295647
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00075643	0.028378341521295647
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.00075643	0.028378341521295647
SCHISIS ASSOCIATION	0.00075643	0.028378341521295647
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00075643	0.028378341521295647
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.00075643	0.028378341521295647
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.028378341521295647
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.00075643	0.028378341521295647
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00075643	0.028378341521295647
DE SANCTIS-CACCHIONE SYNDROME	0.00075643	0.028378341521295647
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00075643	0.028378341521295647
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00075643	0.028378341521295647
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.00075643	0.028378341521295647
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00075643	0.028378341521295647
OROFACIODIGITAL SYNDROME TYPE 14	0.00075643	0.028378341521295647
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00075643	0.028378341521295647
LIG4 SYNDROME	0.00075643	0.028378341521295647
SECKEL SYNDROME 2; SCKL2	0.00075643	0.028378341521295647
RIDDLE SYNDROME	0.00075643	0.028378341521295647
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00075643	0.028378341521295647
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00075643	0.028378341521295647
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00075643	0.028378341521295647
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.00075643	0.028378341521295647
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.00075643	0.028378341521295647
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00075643	0.028378341521295647
RHIZOMELIC SYNDROME	0.00075643	0.028378341521295647
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00075643	0.028378341521295647
601453 TRICHODENTAL DYSPLASIA	0.00075643	0.028378341521295647
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.00075643	0.028378341521295647
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00075643	0.028378341521295647
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00075643	0.028378341521295647
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.00075643	0.028378341521295647
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00075643	0.028378341521295647
TONNE-KALSCHEUER SYNDROME; TOKAS	0.00075643	0.028378341521295647
BARATELA-SCOTT SYNDROME	0.00075643	0.028378341521295647
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.00075643	0.028378341521295647
OGDEN SYNDROME; OGDNS	0.00075643	0.028378341521295647
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00075643	0.028378341521295647
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00075643	0.028378341521295647
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.00075643	0.028378341521295647
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00075643	0.028378341521295647
MASA SYNDROME	0.00075643	0.028378341521295647
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.00075643	0.028378341521295647
LEPRECHAUNISM	0.00075643	0.028378341521295647
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.00075643	0.028378341521295647
%300712 CRANIOFACIOSKELETAL SYNDROME	0.00075643	0.028378341521295647
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00075643	0.028378341521295647
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00075643	0.028378341521295647
MECKEL SYNDROME	0.00075643	0.028378341521295647
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00075643	0.028378341521295647
CHROMOSOME XP11.3 DELETION SYNDROME	0.00075643	0.028378341521295647
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00075643	0.028378341521295647
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.00075643	0.028378341521295647
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00075643	0.028378341521295647
LOWRY-MACLEAN SYNDROME	0.00075643	0.028378341521295647
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00075643	0.028378341521295647
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.00075643	0.028378341521295647
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.00075643	0.028378341521295647
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00075643	0.028378341521295647
OCULOAURICULOFRONTONASAL SYNDROME	0.00075643	0.028378341521295647
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.00075643	0.028378341521295647
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.00075643	0.028378341521295647
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00075643	0.028378341521295647
FACIOCARDIOMELIC SYNDROME	0.00075643	0.028378341521295647
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.00075643	0.028378341521295647
HADZISELIMOVIC SYNDROME	0.00075643	0.028378341521295647
WEAVER-WILLIAMS SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00075643	0.028378341521295647
MMEP SYNDROME	0.00075643	0.028378341521295647
WARSAW BREAKAGE SYNDROME; WABS	0.00075643	0.028378341521295647
MECKEL SYNDROME, TYPE 1; MKS1	0.00075643	0.028378341521295647
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00075643	0.028378341521295647
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00075643	0.028378341521295647
FRONTONASAL DYSPLASIA 2; FND2	0.00075643	0.028378341521295647
HOYERAAL-HREIDARSSON SYNDROME	0.00075643	0.028378341521295647
FORSYTHE-WAKELING SYNDROME; FWS	0.00075643	0.028378341521295647
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00075643	0.028378341521295647
TETRAPLOIDY	0.00075643	0.028378341521295647
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00075643	0.028378341521295647
SECKEL SYNDROME 4	0.00075643	0.028378341521295647
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.00075643	0.028378341521295647
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.00075643	0.028378341521295647
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO ZNF335 DEFICIENCY	0.00075643	0.028378341521295647
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.00075643	0.028378341521295647
HUMERO-RADIAL SYNOSTOSIS	0.00075643	0.028378341521295647
MEIER-GORLIN SYNDROME 3; MGORS3	0.00075643	0.028378341521295647
MEIER-GORLIN SYNDROME 5; MGORS5	0.00075643	0.028378341521295647
SECKEL SYNDROME 5; SCKL5	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00075643	0.028378341521295647
LAMBOTTE SYNDROME	0.00075643	0.028378341521295647
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00075643	0.028378341521295647
XK APROSENCEPHALY SYNDROME	0.00075643	0.028378341521295647
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.028378341521295647
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00075643	0.028378341521295647
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.00075643	0.028378341521295647
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.00075643	0.028378341521295647
GOLDBERG-SHPRINTZEN SYNDROME	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY 5; HPE5	0.00075643	0.028378341521295647
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.00075643	0.028378341521295647
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00075643	0.028378341521295647
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00075643	0.028378341521295647
PSEUDOTRISOMY 13 SYNDROME	0.00075643	0.028378341521295647
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00075643	0.028378341521295647
XYLT1-CDG	0.00075643	0.028378341521295647
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00075643	0.028378341521295647
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00075643	0.028378341521295647
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00075643	0.028378341521295647
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00075643	0.028378341521295647
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00075643	0.028378341521295647
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00075643	0.028378341521295647
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00075643	0.028378341521295647
3MC SYNDROME 1	0.00075643	0.028378341521295647
OCULOPALATOCEREBRAL SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.00075643	0.028378341521295647
MECKEL SYNDROME, TYPE 4; MKS4	0.00075643	0.028378341521295647
MUCOLIPIDOSIS IV; ML4	0.00075643	0.028378341521295647
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00075643	0.028378341521295647
FONTAINE PROGEROID SYNDROME; FPS	0.00075643	0.028378341521295647
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00075643	0.028378341521295647
MICROCEPHALY-CARDIOMYOPATHY	0.00075643	0.028378341521295647
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00075643	0.028378341521295647
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.00075643	0.028378341521295647
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00075643	0.028378341521295647
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.00075643	0.028378341521295647
MEIER-GORLIN SYNDROME 8; MGORS8	0.00075643	0.028378341521295647
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00075643	0.028378341521295647
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00075643	0.028378341521295647
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.00075643	0.028378341521295647
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00075643	0.028378341521295647
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.00075643	0.028378341521295647
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.00075643	0.028378341521295647
SEVERE COMBINED IMMUNODEFICIENCY	0.00075643	0.028378341521295647
2Q32Q33 MICRODELETION SYNDROME	0.00075643	0.028378341521295647
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00075643	0.028378341521295647
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00075643	0.028378341521295647
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.00075643	0.028378341521295647
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.00075643	0.028378341521295647
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
DYSTONIA 28, CHILDHOOD-ONSET	0.00075643	0.028378341521295647
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00075643	0.028378341521295647
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
TOLUENE EMBRYOPATHY	0.00075643	0.028378341521295647
PHENOBARBITAL EMBRYOPATHY	0.00075643	0.028378341521295647
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.00075643	0.028378341521295647
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00075643	0.028378341521295647
46,XX GONADAL DYSGENESIS	0.00075643	0.028378341521295647
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00075643	0.028378341521295647
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00075643	0.028378341521295647
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.00075643	0.028378341521295647
OPTIC ATROPHY 11; OPA11	0.00075643	0.028378341521295647
FETAL METHYLMERCURY SYNDROME	0.00075643	0.028378341521295647
FETAL ALCOHOL SYNDROME	0.00075643	0.028378341521295647
FETAL TRIMETHADIONE SYNDROME	0.00075643	0.028378341521295647
FETAL HYDANTOIN SYNDROME	0.00075643	0.028378341521295647
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00075643	0.028378341521295647
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00075643	0.028378341521295647
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.00075643	0.028378341521295647
DIABETIC EMBRYOPATHY	0.00075643	0.028378341521295647
MICROPHTHALMIA, SYNDROMIC 3	0.00075643	0.028378341521295647
FRASER SYNDROME	0.00075643	0.028378341521295647
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00075643	0.028378341521295647
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.00075643	0.028378341521295647
BLOOM SYNDROME	0.00075643	0.028378341521295647
WILLIAMS SYNDROME	0.00075643	0.028378341521295647
BOWEN-CONRADI SYNDROME	0.00075643	0.028378341521295647
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.00075643	0.028378341521295647
KLIPPEL-TRÉNAUNAY SYNDROME	0.00075643	0.028378341521295647
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00075643	0.028378341521295647
CARDIAC LIPIDOSIS, FAMILIAL	0.00075643	0.028378341521295647
CRI-DU-CHAT SYNDROME	0.00075643	0.028378341521295647
MEIER-GORLIN SYNDROME 6; MGORS6	0.00075643	0.028378341521295647
MARTSOLF SYNDROME	0.00075643	0.028378341521295647
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00075643	0.028378341521295647
SECKEL SYNDROME 9; SCKL9	0.00075643	0.028378341521295647
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.00075643	0.028378341521295647
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00075643	0.028378341521295647
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00075643	0.028378341521295647
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00075643	0.028378341521295647
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00075643	0.028378341521295647
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00075643	0.028378341521295647
TURNPENNY-FRY SYNDROME; TPFS	0.00075643	0.028378341521295647
ALAZAMI-YUAN SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00075643	0.028378341521295647
DYSOSTOSIS, STANESCU TYPE	0.00075643	0.028378341521295647
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.00075643	0.028378341521295647
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00075643	0.028378341521295647
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
BARDET-BIEDL SYNDROME 20	0.00075643	0.028378341521295647
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00075643	0.028378341521295647
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.028378341521295647
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.00075643	0.028378341521295647
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.00075643	0.028378341521295647
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.00075643	0.028378341521295647
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.00075643	0.028378341521295647
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00075643	0.028378341521295647
17Q21.31 MICRODUPLICATION SYNDROME	0.00075643	0.028378341521295647
19Q13.11 MICRODELETION SYNDROME	0.00075643	0.028378341521295647
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00075643	0.028378341521295647
RUVALCABA SYNDROME	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.00075643	0.028378341521295647
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00075643	0.028378341521295647
SAY SYNDROME	0.00075643	0.028378341521295647
IMMUNODEFICIENCY 55; IMD55	0.00075643	0.028378341521295647
ACROCRANIOFACIAL DYSOSTOSIS	0.00075643	0.028378341521295647
FEINGOLD SYNDROME 1; FGLDS1	0.00075643	0.028378341521295647
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00075643	0.028378341521295647
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.00075643	0.028378341521295647
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.00075643	0.028378341521295647
FRYNS-SMEETS-THIRY SYNDROME	0.00075643	0.028378341521295647
GENITOPALATOCARDIAC SYNDROME	0.00075643	0.028378341521295647
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00075643	0.028378341521295647
MONOSOMY 13Q34	0.00075643	0.028378341521295647
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00075643	0.028378341521295647
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00075643	0.028378341521295647
GMS SYNDROME	0.00075643	0.028378341521295647
VERVERI-BRADY SYNDROME; VERBRAS	0.00075643	0.028378341521295647
RING CHROMOSOME 13 SYNDROME	0.00075643	0.028378341521295647
BRAIN-LUNG-THYROID SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00075643	0.028378341521295647
DISTAL TRISOMY 5Q	0.00075643	0.028378341521295647
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00075643	0.028378341521295647
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00075643	0.028378341521295647
LARYNGEAL ABDUCTOR PARALYSIS	0.00075643	0.028378341521295647
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY 3; HPE3	0.00075643	0.028378341521295647
HYPERTRICHOSIS CUBITI	0.00075643	0.028378341521295647
JOHANSON-BLIZZARD SYNDROME	0.00075643	0.028378341521295647
JOHNSON NEUROECTODERMAL SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.00075643	0.028378341521295647
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00075643	0.028378341521295647
JUBERG-HAYWARD SYNDROME	0.00075643	0.028378341521295647
JUNG SYNDROME	0.00075643	0.028378341521295647
HYPERREFLEXIA	0.00075643	0.028378341521295647
VELOCARDIOFACIAL SYNDROME	0.00075643	0.028378341521295647
KERATOSIS FOLLICULARIS-DWARFISM-CEREBRAL ATROPHY SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00075643	0.028378341521295647
TRISOMY 9P	0.00075643	0.028378341521295647
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00075643	0.028378341521295647
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.00075643	0.028378341521295647
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.00075643	0.028378341521295647
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00075643	0.028378341521295647
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00075643	0.028378341521295647
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00075643	0.028378341521295647
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00075643	0.028378341521295647
PRIMARY PULMONARY HYPOPLASIA	0.00075643	0.028378341521295647
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.00075643	0.028378341521295647
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00075643	0.028378341521295647
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00075643	0.028378341521295647
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.00075643	0.028378341521295647
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.028378341521295647
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00075643	0.028378341521295647
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.00075643	0.028378341521295647
HOLMES-GANG SYNDROME	0.00075643	0.028378341521295647
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.00075643	0.028378341521295647
TRISOMY 18P	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.00075643	0.028378341521295647
ENCEPHALOMALACIA, MULTILOCULAR	0.00075643	0.028378341521295647
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00075643	0.028378341521295647
BLOOM SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00075643	0.028378341521295647
FANCONI ANEMIA	0.00075643	0.028378341521295647
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.028378341521295647
BONNEMANN-MEINECKE-REICH SYNDROME	0.00075643	0.028378341521295647
SECKEL SYNDROME 8; SCKL8	0.00075643	0.028378341521295647
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00075643	0.028378341521295647
DESBUQUOIS DYSPLASIA 2; DBQD2	0.00075643	0.028378341521295647
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.028378341521295647
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.00075643	0.028378341521295647
12Q14 MICRODELETION SYNDROME	0.00075643	0.028378341521295647
CRANIOTELENCEPHALIC DYSPLASIA	0.00075643	0.028378341521295647
FEINGOLD SYNDROME	0.00075643	0.028378341521295647
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00075643	0.028378341521295647
PIEBALDISM	0.00075643	0.028378341521295647
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00075643	0.028378341521295647
BARTSOCAS-PAPAS SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00075643	0.028378341521295647
MONOSOMY 5P	0.00075643	0.028378341521295647
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.00075643	0.028378341521295647
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.00075643	0.028378341521295647
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00075643	0.028378341521295647
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00075643	0.028378341521295647
NEU-LAXOVA SYNDROME 2; NLS2	0.00075643	0.028378341521295647
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00075643	0.028378341521295647
DISTAL MONOSOMY 17Q	0.00075643	0.028378341521295647
DISTAL MONOSOMY 13Q	0.00075643	0.028378341521295647
MONOSOMY 13Q14	0.00075643	0.028378341521295647
LIG4 SYNDROME	0.00075643	0.028378341521295647
DISTAL MONOSOMY 10P	0.00075643	0.028378341521295647
OROFACIODIGITAL SYNDROME XIV; OFD14	0.00075643	0.028378341521295647
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00075643	0.028378341521295647
DIAMOND-BLACKFAN ANEMIA 1	0.00075643	0.028378341521295647
1Q21.1 RECURRENT MICRODELETION (SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00075643	0.028378341521295647
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00075643	0.028378341521295647
CAREY-FINEMAN-ZITER SYNDROME	0.00075643	0.028378341521295647
BRESEK SYNDROME	0.00075643	0.028378341521295647
CRI DU CHAT SYNDROME (5P DELETION)	0.00075643	0.028378341521295647
RING CHROMOSOME 1 SYNDROME	0.00075643	0.028378341521295647
CEREBROCOSTOMANDIBULAR SYNDROME	0.00075643	0.028378341521295647
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.00075643	0.028378341521295647
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00075643	0.028378341521295647
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.028378341521295647
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00075643	0.028378341521295647
OTOMANDIBULAR SYNDROME	0.00075643	0.028378341521295647
ACROOTOOCULAR SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00075643	0.028378341521295647
PSEUDOPROGERIA SYNDROME	0.00075643	0.028378341521295647
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.00075643	0.028378341521295647
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00075643	0.028378341521295647
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00075643	0.028378341521295647
RING CHROMOSOME 12 SYNDROME	0.00075643	0.028378341521295647
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.00075643	0.028378341521295647
9Q SUBTELOMERIC DELETION SYNDROME	0.00075643	0.028378341521295647
MICROTRIPLICATION 11Q24.1	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00075643	0.028378341521295647
3Q29 MICRODELETION SYNDROME	0.00075643	0.028378341521295647
MILLER-DIEKER SYNDROME (MDS)	0.00075643	0.028378341521295647
RING CHROMOSOME 7 SYNDROME	0.00075643	0.028378341521295647
CONGENITAL VARICELLA SYNDROME	0.00075643	0.028378341521295647
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00075643	0.028378341521295647
POLAND SYNDROME	0.00075643	0.028378341521295647
OROFACIODIGITAL SYNDROME TYPE 5	0.00075643	0.028378341521295647
HARTSFIELD SYNDROME; HRTFDS	0.00075643	0.028378341521295647
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.00075643	0.028378341521295647
RING CHROMOSOME 6 SYNDROME	0.00075643	0.028378341521295647
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00075643	0.028378341521295647
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00075643	0.028378341521295647
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.00075643	0.028378341521295647
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00075643	0.028378341521295647
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00075643	0.028378341521295647
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.00075643	0.028378341521295647
CHARGE SYNDROME	0.00075643	0.028378341521295647
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00075643	0.028378341521295647
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00075643	0.028378341521295647
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.00075643	0.028378341521295647
DUBOWITZ SYNDROME	0.00075643	0.028378341521295647
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
YUNIS-VARON SYNDROME	0.00075643	0.028378341521295647
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.00075643	0.028378341521295647
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.00075643	0.028378341521295647
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00075643	0.028378341521295647
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.028378341521295647
NON-DISTAL TRISOMY 13Q	0.00075643	0.028378341521295647
ISOLATED OSTEOPOIKILOSIS	0.00075643	0.028378341521295647
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00075643	0.028378341521295647
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00075643	0.028378341521295647
PAGOD SYNDROME	0.00075643	0.028378341521295647
NON-DISTAL TRISOMY 10Q	0.00075643	0.028378341521295647
OCULO-PALATO-CEREBRAL SYNDROME	0.00075643	0.028378341521295647
CRANIOSYNOSTOSIS 6; CRS6	0.00075643	0.028378341521295647
AL-RAQAD SYNDROME; ARS	0.00075643	0.028378341521295647
CEREBELLOFACIODENTAL SYNDROME	0.00075643	0.028378341521295647
TOWNES-BROCKS SYNDROME 1; TBS1	0.00075643	0.028378341521295647
COFFIN-SIRIS SYNDROME 10; CSS10	0.00075643	0.028378341521295647
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00075643	0.028378341521295647
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00075643	0.028378341521295647
CERNUNNOS-XLF DEFICIENCY	0.00075643	0.028378341521295647
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.00075643	0.028378341521295647
17P11.2 MICRODUPLICATION SYNDROME	0.00075643	0.028378341521295647
ANONYCHIA-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
OKAMOTO SYNDROME	0.00075643	0.028378341521295647
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00075643	0.028378341521295647
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00075643	0.028378341521295647
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.00075643	0.028378341521295647
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.00075643	0.028378341521295647
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.00075643	0.028378341521295647
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.00075643	0.028378341521295647
49,XXXXY SYNDROME	0.000541419	0.020311956543392476
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.020311956543392476
48,XXXY SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000541419	0.020311956543392476
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020311956543392476
DARIER-WHITE DISEASE; DAR	0.000541419	0.020311956543392476
MYASTHENIA GRAVIS	0.000541419	0.020311956543392476
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020311956543392476
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.020311956543392476
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.020311956543392476
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020311956543392476
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.020311956543392476
THYROCEREBRORETINAL SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020311956543392476
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
MUCOPOLYSACCHARIDOSIS TYPE 3	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020311956543392476
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.020311956543392476
1P36 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.020311956543392476
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392476
CROUZON SYNDROME	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392476
WYBURN-MASON SYNDROME	0.000541419	0.020311956543392476
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000541419	0.020311956543392476
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392476
ONDINE SYNDROME	0.000541419	0.020311956543392476
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.020311956543392476
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392476
HUNTINGTON DISEASE; HD	0.000541419	0.020311956543392476
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020311956543392476
CLARK-BARAITSER SYNDROME	0.000541419	0.020311956543392476
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020311956543392476
DERMOTRICHIC SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020311956543392476
ADRENOLEUKODYSTROPHY	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020311956543392476
NETHERTON SYNDROME	0.000541419	0.020311956543392476
RAYNAUD-CLAES SYNDROME; MRXSRC	0.000541419	0.020311956543392476
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020311956543392476
HADDAD SYNDROME	0.000541419	0.020311956543392476
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 72	0.000541419	0.020311956543392476
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.020311956543392476
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020311956543392476
FLYNN-AIRD SYNDROME	0.000541419	0.020311956543392476
ZIMMERMANN-LABAND SYNDROME 1	0.000541419	0.020311956543392476
CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392476
NIEMANN-PICK DISEASE TYPE C	0.000541419	0.020311956543392476
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.020311956543392476
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020311956543392476
LHERMITTE-DUCLOS DISEASE	0.000541419	0.020311956543392476
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392476
CRANIOPHARYNGIOMA	0.000541419	0.020311956543392476
EPILEPSY, READING	0.000541419	0.020311956543392476
2Q33.1 DELETION SYNDROME	0.000541419	0.020311956543392476
ATKIN-FLAITZ SYNDROME	0.000541419	0.020311956543392476
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.020311956543392476
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020311956543392476
ADAMS-OLIVER SYNDROME	0.000541419	0.020311956543392476
ADRENOMYODYSTROPHY	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 88	0.000541419	0.020311956543392476
PALLISTER-HALL SYNDROME	0.000541419	0.020311956543392476
RECURRENT ACUTE PANCREATITIS	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 90	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020311956543392476
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000541419	0.020311956543392476
PAPILLORENAL SYNDROME	0.000541419	0.020311956543392476
TAY-SACHS DISEASE	0.000541419	0.020311956543392476
THREONINEMIA	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS	0.000541419	0.020311956543392476
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.000541419	0.020311956543392476
TEMTAMY SYNDROME; TEMTYS	0.000541419	0.020311956543392476
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.020311956543392476
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.020311956543392476
SAETHRE-CHOTZEN SYNDROME	0.000541419	0.020311956543392476
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000541419	0.020311956543392476
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000541419	0.020311956543392476
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.000541419	0.020311956543392476
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.020311956543392476
KIFAFA SEIZURE DISORDER	0.000541419	0.020311956543392476
KETOADIPICACIDURIA	0.000541419	0.020311956543392476
DIAMINOPENTANURIA	0.000541419	0.020311956543392476
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.000541419	0.020311956543392476
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.020311956543392476
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000541419	0.020311956543392476
DYSOSTEOSCLEROSIS	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020311956543392476
MOGS-CDG	0.000541419	0.020311956543392476
ALG9-CDG	0.000541419	0.020311956543392476
LANDAU-KLEFFNER SYNDROME	0.000541419	0.020311956543392476
GRISCELLI SYNDROME, TYPE 1	0.000541419	0.020311956543392476
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020311956543392476
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.020311956543392476
HEREDITARY FOLATE MALABSORPTION	0.000541419	0.020311956543392476
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.020311956543392476
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.020311956543392476
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020311956543392476
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000541419	0.020311956543392476
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.020311956543392476
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.000541419	0.020311956543392476
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020311956543392476
ARGININEMIA	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.020311956543392476
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.020311956543392476
CITRULLINEMIA, CLASSIC	0.000541419	0.020311956543392476
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.000541419	0.020311956543392476
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392476
MPDU1-CDG	0.000541419	0.020311956543392476
PORPHYRIA VARIEGATA	0.000541419	0.020311956543392476
EPILEPSY-TELANGIECTASIA	0.000541419	0.020311956543392476
DISTAL MONOSOMY 19P13.3	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000541419	0.020311956543392476
HYPERPROLINEMIA, TYPE II	0.000541419	0.020311956543392476
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020311956543392476
ISOLATED SPINA BIFIDA	0.000541419	0.020311956543392476
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.000541419	0.020311956543392476
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.020311956543392476
HYPERLYSINEMIA, TYPE I	0.000541419	0.020311956543392476
KEUTEL SYNDROME	0.000541419	0.020311956543392476
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.020311956543392476
BERNARD-SOULIER SYNDROME	0.000541419	0.020311956543392476
HYPER-BETA-ALANINEMIA	0.000541419	0.020311956543392476
SCRUB TYPHUS	0.000541419	0.020311956543392476
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
ENCEPHALITIS LETHARGICA	0.000541419	0.020311956543392476
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000541419	0.020311956543392476
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.020311956543392476
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.020311956543392476
GAUCHER DISEASE, TYPE II	0.000541419	0.020311956543392476
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
SCHIZENCEPHALY	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.020311956543392476
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392476
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.020311956543392476
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020311956543392476
FOLATE MALABSORPTION, HEREDITARY	0.000541419	0.020311956543392476
SANDHOFF DISEASE	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.000541419	0.020311956543392476
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.020311956543392476
47,XYY SYNDROME	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020311956543392476
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.000541419	0.020311956543392476
FOUNTAIN SYNDROME	0.000541419	0.020311956543392476
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.020311956543392476
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020311956543392476
HEREDITARY COPROPORPHYRIA	0.000541419	0.020311956543392476
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.020311956543392476
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392476
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.020311956543392476
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392476
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020311956543392476
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.020311956543392476
RAMON SYNDROME	0.000541419	0.020311956543392476
PYRUVATE CARBOXYLASE DEFICIENCY	0.000541419	0.020311956543392476
DIGEORGE SYNDROME; DGS	0.000541419	0.020311956543392476
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020311956543392476
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.020311956543392476
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000541419	0.020311956543392476
HARTNUP DISORDER	0.000541419	0.020311956543392476
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.020311956543392476
PROTEUS SYNDROME	0.000541419	0.020311956543392476
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020311956543392476
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.020311956543392476
PEHO SYNDROME; PEHO	0.000541419	0.020311956543392476
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020311956543392476
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000541419	0.020311956543392476
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392476
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392476
FAMILIAL THROMBOCYTOSIS	0.000541419	0.020311956543392476
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020311956543392476
7Q11.23 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
TAY-SACHS DISEASE; TSD	0.000541419	0.020311956543392476
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392476
SULFOCYSTEINURIA	0.000541419	0.020311956543392476
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020311956543392476
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020311956543392476
PARIETAL FORAMINA	0.000541419	0.020311956543392476
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.020311956543392476
PARTINGTON SYNDROME	0.000541419	0.020311956543392476
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.020311956543392476
PITUITARY STALK INTERRUPTION SYNDROME	0.000541419	0.020311956543392476
PRADER-WILLI SYNDROME; PWS	0.000541419	0.020311956543392476
COG8-CDG	0.000541419	0.020311956543392476
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.020311956543392476
SMITH-MAGENIS SYNDROME; SMS	0.000541419	0.020311956543392476
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.020311956543392476
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000541419	0.020311956543392476
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000541419	0.020311956543392476
ARGININOSUCCINIC ACIDURIA	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000541419	0.020311956543392476
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.020311956543392476
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.020311956543392476
FRAGILE X SYNDROME	0.000541419	0.020311956543392476
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.020311956543392476
AUTISM	0.000541419	0.020311956543392476
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000541419	0.020311956543392476
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000541419	0.020311956543392476
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.000541419	0.020311956543392476
OHDO SYNDROME	0.000541419	0.020311956543392476
DEND SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020311956543392476
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.000541419	0.020311956543392476
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000541419	0.020311956543392476
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000541419	0.020311956543392476
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020311956543392476
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020311956543392476
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.020311956543392476
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.020311956543392476
ASPARTYLGLUCOSAMINURIA	0.000541419	0.020311956543392476
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.020311956543392476
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.020311956543392476
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020311956543392476
RABIES	0.000541419	0.020311956543392476
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392476
PFEIFFER SYNDROME TYPE 2	0.000541419	0.020311956543392476
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.000541419	0.020311956543392476
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.020311956543392476
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.020311956543392476
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.020311956543392476
ALEXANDER DISEASE	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.020311956543392476
MONOSOMY 9Q22.3	0.000541419	0.020311956543392476
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.020311956543392476
MILLER-DIEKER SYNDROME	0.000541419	0.020311956543392476
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 49; IMD49	0.000541419	0.020311956543392476
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020311956543392476
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000541419	0.020311956543392476
SHASHI-PENA SYNDROME; SHAPNS	0.000541419	0.020311956543392476
EPENDYMOMA	0.000541419	0.020311956543392476
SUBEPENDYMOMA	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000541419	0.020311956543392476
PINEOBLASTOMA	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000541419	0.020311956543392476
KAGAMI-OGATA SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020311956543392476
AICA-RIBOSIDURIA	0.000541419	0.020311956543392476
MICROSPORIDIOSIS	0.000541419	0.020311956543392476
MIRAGE SYNDROME; MIRAGE	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.020311956543392476
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000541419	0.020311956543392476
MOYAMOYA DISEASE	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000541419	0.020311956543392476
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000541419	0.020311956543392476
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000541419	0.020311956543392476
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020311956543392476
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392476
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000541419	0.020311956543392476
CHROMOSOME 16P13.2 DELETION SYNDROME	0.000541419	0.020311956543392476
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.020311956543392476
17Q24.2 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020311956543392476
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.000541419	0.020311956543392476
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000541419	0.020311956543392476
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000541419	0.020311956543392476
JACOBSEN SYNDROME	0.000541419	0.020311956543392476
JOUBERT SYNDROME 30; JBTS30	0.000541419	0.020311956543392476
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000541419	0.020311956543392476
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000541419	0.020311956543392476
15Q11Q13 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
4Q21 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000541419	0.020311956543392476
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.020311956543392476
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000541419	0.020311956543392476
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
CENTRAL BILATERAL MACROGYRIA	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.000541419	0.020311956543392476
CITRULLINEMIA TYPE I	0.000541419	0.020311956543392476
CITRULLINEMIA TYPE II	0.000541419	0.020311956543392476
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.020311956543392476
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000541419	0.020311956543392476
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020311956543392476
JUVENILE HUNTINGTON DISEASE	0.000541419	0.020311956543392476
LUSCAN-LUMISH SYNDROME; LLS	0.000541419	0.020311956543392476
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.000541419	0.020311956543392476
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000541419	0.020311956543392476
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020311956543392476
NASU-HAKOLA DISEASE	0.000541419	0.020311956543392476
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392476
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.020311956543392476
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000541419	0.020311956543392476
WEBB-DATTANI SYNDROME; WEDAS	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000541419	0.020311956543392476
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.020311956543392476
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.020311956543392476
HELSMOORTEL-VAN DER AA SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000541419	0.020311956543392476
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392476
TARP SYNDROME	0.000541419	0.020311956543392476
CHROMOSOME 5Q12 DELETION SYNDROME	0.000541419	0.020311956543392476
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000541419	0.020311956543392476
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392476
L1 SYNDROME	0.000541419	0.020311956543392476
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020311956543392476
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.020311956543392476
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020311956543392476
DISTAL 16P11.2 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
17Q12 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
20P12.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
DESANTO-SHINAWI SYNDROME	0.000541419	0.020311956543392476
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000541419	0.020311956543392476
SMITH-KINGSMORE SYNDROME; SKS	0.000541419	0.020311956543392476
XP21 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020311956543392476
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020311956543392476
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000541419	0.020311956543392476
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000541419	0.020311956543392476
THANATOPHORIC DYSPLASIA	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000541419	0.020311956543392476
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000541419	0.020311956543392476
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000541419	0.020311956543392476
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000541419	0.020311956543392476
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020311956543392476
TENORIO SYNDROME; TNORS	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000541419	0.020311956543392476
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000541419	0.020311956543392476
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020311956543392476
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.000541419	0.020311956543392476
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.020311956543392476
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020311956543392476
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020311956543392476
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.020311956543392476
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.000541419	0.020311956543392476
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000541419	0.020311956543392476
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000541419	0.020311956543392476
DYSEQUILIBRIUM SYNDROME	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000541419	0.020311956543392476
CENTRAL DIABETES INSIPIDUS	0.000541419	0.020311956543392476
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000541419	0.020311956543392476
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.020311956543392476
ACROMELIC FRONTONASAL DYSPLASIA	0.000541419	0.020311956543392476
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000541419	0.020311956543392476
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392476
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.020311956543392476
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020311956543392476
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.020311956543392476
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020311956543392476
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020311956543392476
ROMANO-WARD SYNDROME	0.000541419	0.020311956543392476
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.000541419	0.020311956543392476
RING CHROMOSOME 10 SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000541419	0.020311956543392476
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000541419	0.020311956543392476
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION	0.000541419	0.020311956543392476
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020311956543392476
MULTIPLE CARBOXYLASE DEFICIENCY	0.000541419	0.020311956543392476
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.020311956543392476
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
CRYPTOCOCCOSIS	0.000541419	0.020311956543392476
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020311956543392476
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020311956543392476
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.020311956543392476
BETA-MANNOSIDOSIS	0.000541419	0.020311956543392476
ROSAÏ-DORFMAN DISEASE	0.000541419	0.020311956543392476
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.020311956543392476
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.020311956543392476
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020311956543392476
2P21 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020311956543392476
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020311956543392476
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000541419	0.020311956543392476
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.020311956543392476
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.020311956543392476
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020311956543392476
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
EPISODIC ATAXIA TYPE 6	0.000541419	0.020311956543392476
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000541419	0.020311956543392476
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.000541419	0.020311956543392476
CYSTATHIONINURIA	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.020311956543392476
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000541419	0.020311956543392476
DONNAI-BARROW SYNDROME	0.000541419	0.020311956543392476
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020311956543392476
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392476
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392476
NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
FRONTAL ENCEPHALOCELE	0.000541419	0.020311956543392476
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.020311956543392476
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020311956543392476
HYDRANENCEPHALY	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.020311956543392476
CONGENITAL HYDROCEPHALUS	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.000541419	0.020311956543392476
SOTOS SYNDROME	0.000541419	0.020311956543392476
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020311956543392476
PITT-HOPKINS-LIKE SYNDROME	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000541419	0.020311956543392476
NEPHROGENIC DIABETES INSIPIDUS	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392476
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.020311956543392476
FRYNS SYNDROME	0.000541419	0.020311956543392476
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000541419	0.020311956543392476
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000541419	0.020311956543392476
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000541419	0.020311956543392476
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392476
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.020311956543392476
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000541419	0.020311956543392476
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.000541419	0.020311956543392476
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000541419	0.020311956543392476
EAST SYNDROME	0.000541419	0.020311956543392476
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392476
COWDEN SYNDROME	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000541419	0.020311956543392476
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.020311956543392476
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020311956543392476
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.020311956543392476
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.020311956543392476
FLYNN-AIRD SYNDROME	0.000541419	0.020311956543392476
FOIX-CHAVANY-MARIE SYNDROME	0.000541419	0.020311956543392476
CRIGLER-NAJJAR SYNDROME	0.000541419	0.020311956543392476
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.000541419	0.020311956543392476
ISOLATED GLYCEROL KINASE DEFICIENCY	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000541419	0.020311956543392476
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020311956543392476
LISSENCEPHALY 1; LIS1	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000541419	0.020311956543392476
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
DYSTONIA-APHONIA SYNDROME	0.000541419	0.020311956543392476
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.020311956543392476
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020311956543392476
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.020311956543392476
KUFOR-RAKEB SYNDROME	0.000541419	0.020311956543392476
PROPIONIC ACIDEMIA	0.000541419	0.020311956543392476
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000541419	0.020311956543392476
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
WIEDEMANN-STEINER SYNDROME; WDSTS	0.000541419	0.020311956543392476
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392476
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392476
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS 2	0.000541419	0.020311956543392476
PGM3-CDG	0.000541419	0.020311956543392476
11Q22.2Q22.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.000541419	0.020311956543392476
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.000541419	0.020311956543392476
NIEMANN-PICK DISEASE, TYPE C2	0.000541419	0.020311956543392476
ALZHEIMER DISEASE 3; AD	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000541419	0.020311956543392476
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.000541419	0.020311956543392476
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000541419	0.020311956543392476
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.020311956543392476
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020311956543392476
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000541419	0.020311956543392476
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000541419	0.020311956543392476
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.000541419	0.020311956543392476
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392476
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000541419	0.020311956543392476
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.000541419	0.020311956543392476
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.000541419	0.020311956543392476
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020311956543392476
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.000541419	0.020311956543392476
MAN1B1-CDG	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.020311956543392476
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.000541419	0.020311956543392476
MEND SYNDROME	0.000541419	0.020311956543392476
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.020311956543392476
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.000541419	0.020311956543392476
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.020311956543392476
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
MAPLE SYRUP URINE DISEASE	0.000541419	0.020311956543392476
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.000541419	0.020311956543392476
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.020311956543392476
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 9	0.000541419	0.020311956543392476
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.020311956543392476
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020311956543392476
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020311956543392476
GLYCEROL KINASE DEFICIENCY; GKD	0.000541419	0.020311956543392476
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.020311956543392476
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000541419	0.020311956543392476
8Q24.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
ETHYLMALONIC ENCEPHALOPATHY	0.000541419	0.020311956543392476
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000541419	0.020311956543392476
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000541419	0.020311956543392476
SHUKLA-VERNON SYNDROME; SHUVER	0.000541419	0.020311956543392476
XQ25 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 103	0.000541419	0.020311956543392476
XQ25 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 47	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.000541419	0.020311956543392476
MEND SYNDROME; MEND	0.000541419	0.020311956543392476
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020311956543392476
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020311956543392476
WAISMAN SYNDROME; WSMN	0.000541419	0.020311956543392476
RETT SYNDROME; RTT	0.000541419	0.020311956543392476
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000541419	0.020311956543392476
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000541419	0.020311956543392476
MUENKE SYNDROME	0.000541419	0.020311956543392476
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.020311956543392476
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000541419	0.020311956543392476
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000541419	0.020311956543392476
GRACILE BONE DYSPLASIA; GCLEB	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392476
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020311956543392476
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000541419	0.020311956543392476
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.000541419	0.020311956543392476
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.000541419	0.020311956543392476
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020311956543392476
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020311956543392476
GURRIERI SYNDROME	0.000541419	0.020311956543392476
TIMOTHY SYNDROME; TS	0.000541419	0.020311956543392476
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.020311956543392476
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020311956543392476
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
CHROMOSOME 2Q37 DELETION SYNDROME	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392476
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.020311956543392476
MONOSOMY 22Q13.3	0.000541419	0.020311956543392476
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.020311956543392476
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000541419	0.020311956543392476
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000541419	0.020311956543392476
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000541419	0.020311956543392476
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.000541419	0.020311956543392476
COFFIN-SIRIS SYNDROME 2; CSS2	0.000541419	0.020311956543392476
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.020311956543392476
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000541419	0.020311956543392476
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000541419	0.020311956543392476
SEVERE CANAVAN DISEASE	0.000541419	0.020311956543392476
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020311956543392476
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000541419	0.020311956543392476
SIALURIA	0.000541419	0.020311956543392476
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.000541419	0.020311956543392476
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.020311956543392476
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000541419	0.020311956543392476
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000541419	0.020311956543392476
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.020311956543392476
HEREDITARY HYPEREKPLEXIA	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020311956543392476
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.020311956543392476
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392476
FOUNTAIN SYNDROME	0.000541419	0.020311956543392476
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020311956543392476
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.020311956543392476
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020311956543392476
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000541419	0.020311956543392476
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020311956543392476
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.000541419	0.020311956543392476
PORENCEPHALY	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000541419	0.020311956543392476
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.020311956543392476
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020311956543392476
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000541419	0.020311956543392476
LISSENCEPHALY 5; LIS5	0.000541419	0.020311956543392476
11P15.4 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
DDOST-CDG	0.000541419	0.020311956543392476
COWDEN SYNDROME 6; CWS6	0.000541419	0.020311956543392476
QAZI-MARKOUIZOS SYNDROME	0.000541419	0.020311956543392476
RAMON SYNDROME	0.000541419	0.020311956543392476
COWDEN SYNDROME 5; CWS5	0.000541419	0.020311956543392476
ISOLATED BILIARY ATRESIA	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000541419	0.020311956543392476
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000541419	0.020311956543392476
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000541419	0.020311956543392476
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.020311956543392476
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020311956543392476
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.020311956543392476
CORNELIA DE LANGE SYNDROME 3	0.000541419	0.020311956543392476
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000541419	0.020311956543392476
WILSON-TURNER SYNDROME	0.000541419	0.020311956543392476
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000541419	0.020311956543392476
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.020311956543392476
CHIME SYNDROME	0.000541419	0.020311956543392476
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
FUCOSIDOSIS	0.000541419	0.020311956543392476
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000541419	0.020311956543392476
GALACTOSIALIDOSIS	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.020311956543392476
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.000541419	0.020311956543392476
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392476
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.020311956543392476
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000541419	0.020311956543392476
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020311956543392476
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000541419	0.020311956543392476
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.020311956543392476
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000541419	0.020311956543392476
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.000541419	0.020311956543392476
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000541419	0.020311956543392476
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392476
HOLOPROSENCEPHALY 7	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000541419	0.020311956543392476
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000541419	0.020311956543392476
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.020311956543392476
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020311956543392476
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020311956543392476
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.020311956543392476
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000541419	0.020311956543392476
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.020311956543392476
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000541419	0.020311956543392476
NOONAN SYNDROME 7; NS7	0.000541419	0.020311956543392476
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.000541419	0.020311956543392476
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.000541419	0.020311956543392476
ISOVALERIC ACIDEMIA	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000541419	0.020311956543392476
TETRASOMY 5P	0.000541419	0.020311956543392476
THYROCEREBRORENAL SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.020311956543392476
RETT SYNDROME, CONGENITAL VARIANT	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.020311956543392476
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.020311956543392476
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392476
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.020311956543392476
TRISOMY X	0.000541419	0.020311956543392476
TRISOMY 13	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.020311956543392476
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
GABA-TRANSAMINASE DEFICIENCY	0.000541419	0.020311956543392476
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020311956543392476
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.020311956543392476
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000541419	0.020311956543392476
